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Recently rates of Food Allergies (FA) in children have been increasing in prevalence.  
International research has shown FA is associated with impaired Health-Related Quality of Life 
(HRQoL) as well as increased anxiety in both children and parents of children with FA.  This was the 
first study to examine FA-specific factors with psychological variables in New Zealand children with 
FA.  The aim of the study was to examine the relationship between FA severity and child HRQoL, as 
well as to investigate moderating variables, such as parent anxiety and parental burden associated with 
FA and child HRQoL.  The sample consisted of 154 children with FA and their caregivers, recruited 
though social media and email newsletters.  Caregivers completed questionnaires assessing 
demographics, FA characteristics, child and parent measures of anxiety, child reported and parent 
reported child HRQoL, and disease burden.   
It was hypothesised that (1) children with FA would report lower levels of HRQoL compared 
to healthy controls (2) children with multiple FA would report poorer HRQoL compared to children 
with one or two FA’s (3) FA severity would be associated with low levels of child HRQoL (4) 
primary caregiver’s anxiety would moderate the relationship between FA and HRQoL (5) primary 
caregiver’s sense of perceived burden would moderate the relationship between FA and HRQoL.   
Results indicated that (1) children with FA exhibited significantly poorer HRQoL compared to 
healthy children; (2)  children with multiple allergies did not report significantly poorer HRQoL 
compared to children with one or two FA’s; (3) higher FA severity predicted poorer child HRQoL as 
reported by parents but not children; (4) the association between FA severity and child HRQoL was 
not moderated by caregiver anxiety; and (5) the association between FA severity and HRQoL was not 
moderated by parent burden.  These findings suggest that children with FA and their caregivers in 




FA.  Finally, these findings may help inform future clinical efforts that are specifically designed to 
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Food Allergy (FA) is an adverse, abnormal reaction to food proteins stemming from the 
immune system (Allen, Hill, & Heine, 2006; Knibb & Stalker, 2013) with a range of symptoms that 
can affect the cardiovascular, respiratory, skin, and digestive systems.  These symptoms can be mild 
(e.g., itchiness) or they can be extremely severe, as with anaphylaxis, which requires a life-saving 
injection of adrenaline.  Current estimates of FA worldwide suggest a prevalence rate of 
approximately 6-7% of children (Boyle et al., 2017).  Although gaining accurate prevalence rates from 
research is challenging, due to lack of objectively assessed reliable data, FA rates appear to be 
increasing in Western countries such as the United Kingdom, Australia, and the United States 
(Sicherer & Sampson, 2018; Tang & Mullins, 2017).  It is thought that rates will continue to steadily 
rise in developing countries as they start to adopt a more Westernised lifestyle due to evidence that 
children from areas such as East Asia have increased risk of developing FA when exposed to Western 
diets than do Caucasian children (Tang & Mullins, 2017).  The increasing prevalence is particularly 
noticeable in older children and adolescents, which is concerning given that the rate of fatalities from 
FA reactions are highest in this age group (Bock, Muñoz-Furlong, & Sampson, 2007).  It is thought 
that these prevalence rates will continue to rise globally over the short to medium term until a cure for 
FA or effective treatment is discovered (Tang & Mullins, 2017). Presently, there are no reliable 
prevalence statistics for childhood FA in New Zealand (Crooks et al, 2008). 
It is not difficult to imagine the economic impact FA can have, when one considers both the 
prevalence of the illness and the time families spend managing it.  Although there are no estimates of 
medical costs related to FA in New Zealand, preventing and treating FA in children costs nearly 25 




presenting with FA having experienced a life-threatening reaction (Bilaver, Kester, Smith & Gupta, 
2016; Gupta et al., 2013).  The majority of these costs are borne by the families and include lost 
labour, due to needing to take time off work to care for these children, and out-of-pocket expenses for 
specialty foods (Gupta et al., 2013).  A recent study by Protudjer and colleagues (2015) indicated that 
both direct (e.g., medications) and indirect (e.g., time spent at medical appointments, shopping, etc.) 
household costs associated with FA, were approximately 4000 Euro higher in FA households with 
children and 4800 Euro higher in FA households with adolescents among Swedish families.  
To gain a better understanding of the aforementioned findings related to the time families with 
FA spend on illness related issues, it is important to examine the treatment of FA. Although there has 
been some success with specific treatment methods, such as oral immunotherapy (Bégin et al., 2014), 
which aim to create desensitisation, these therapies are currently mostly available only in research 
settings and a select few private practices of board-certified allergists.  To date, there are no options 
for oral immunotherapy to food in New Zealand, and the safety and efficacy of these particular 
treatment options are still being established (Sampath, Sindher, Zhang & Nadeau, 2018).  Further, the 
specific features of the therapy, such as the length of time the children treated need to keep consuming 
a maintenance daily dose to prevent sensitisation returning, are also still being established (Sicherer & 
Sampson, 2017).  Although the number of ongoing studies examining a range of therapies is exciting, 
at present there is no publicly available cure for FA recommended by the major allergy organisations 
such as the National Institute of Allergy and Infectious Diseases (Boyce et al, 2011).  Thus, 
management involves strict avoidance of the allergen, constant vigilance and rapid treatment when an 
allergic reaction occurs, all of which require a high level of education and vigilance for the patient and 
the caregiver (Sicherer & Sampson, 2017).  This can be difficult, since common allergens such as 
milk and egg are found in many commercial food products.  Successful avoidance involves efforts 
from both the child with FA and their parents, but also includes trust in the wider community (e.g., the 




Sampson, 2017).  The problem of strict avoidance is compounded, as there is a large variation in 
clear labeling of these products, which requires constant ingredient checking by children, adolescents, 
and caregivers.  As one might assume, this constant vigilance has been found to affect the wellbeing 
of the child with FA and their families (Bollinger et al., 2006).   
Parental burden in families with food allergy 
	
 As one can imagine, parents of children with FA report a high sense of burden related to 
looking after their children (Bollinger et al., 2006).  Within the context of FA, burden refers to a range 
of different domains and emotional issues related to caring for a child with FA.  Specifically, burden 
captures the difficulties of family/social activities (e.g. school activities, eating at restaurants, 
attending parties), leaving children in the care of others, letting children sit near others while eating, 
the time required for meal preparation, health and nutritional concerns, fear about their ability to help 
in the case of a future allergic reaction, and sadness and worry about their child’s future (Cohen,  
Noone, Muñoz-Furlong & Sicherer, 2004).  Nearly half of parents in a recent study investigating FA-
related burden reported moderate to severe limitations in caring for their family, such as planning 
social activities, eating out, and entrusting their children’s care to others (Allen, Bidarkar, vanNunen 
& Campbell, 2015).   
One of the primary factors shown to affect parental burden includes the number of allergies a 
child has (Allen et al., 2015).  In fact, the relationship between the number of FAs and parent-
perceived burden is stronger than needing to carry an adrenaline auto-injector (a.k.a., Epipen) 
constantly, which is another factor known to increase the burden within families with FA (Allen et al., 
2015).  These findings become particularly concerning when one considers the impact this burden can 
have on the daily lives of children with FA and their families.   
Specifically, research has shown that FA has a significant impact on the day-to-day lives of 
families, affecting family social activities, meal preparation, school attendance, and family stress 




approximately 10% of families with a child who has an FA, choose to home school their children 
due to their concerns about keeping them safe from allergens (Bollinger, 2016).  Parents also admit 
avoiding school camps, school outings, sending children to preschool or day-care, going to 
restaurants, letting their children go to friend’s houses for play dates, camps, and sleepovers 
(Bollinger et al., 2016).  Valentine and Knibb (2011) found that the burden of responsibility for caring 
for children with FA impacted on parents much more than children.  In a similar study, Springston and 
colleagues (2010) found a wide variation in scores on the Food Allergy Quality of Life-Parental 
burden scale (FAQL-PB; Cohen, Noone, Muñoz-Furlong, & Sicherer, 2004), a measure designed to 
evaluate the impact FA has on a child’s quality of life, with nearly all participants at least moderately 
troubled by social interactions and limitations.  These authors also found that parental burden was 
higher for parents of children with multiple allergies, with approximately 65% of the sample reporting 
moderate or extreme discontent with the extra time required to prepare safe meals for their child with 
FA. 
Health-Related Quality of Life	
 In addition to the aforementioned problems the families of children with FA can face, FA can 
impact the lives of the child in many other ways, particularly their HRQoL.  HRQoL can be described 
as an individual’s perception of the influence of health status on physical, psychological, and social 
functioning, which is multidimensional and subjective in nature and has become a popular outcome 
measure for helping researchers and clinicians understand the impact illness can have on a child or 
adolescent (Matza, Swensen, Flood, Secnik, & Leidy, 2004).  Because children exist in unique 
contexts (e.g., family, school, peers), which can mediate the impact of chronic disease on well-being, 
child measures of HRQoL must take these factors into account.  That is, HRQoL measures are 
important, as they are able to examine a broad range of outcomes and measure the impact of chronic 
disease on overall functioning, rather than exclusively capturing clinical indicators of health (e.g., 
itching, hives, wheezing).  Ideally, this is able to help provide more effective treatments for children 




having on the “whole child.”  It is intuitive that both adults and children with FA report significantly 
lower levels of HRQoL than their healthy counterparts (Primeau et al., 2000; Valentine & Knibb, 
2011) and children without FA (King, Knibb & Hourihane, 2009).  
Anxiety  
Although the majority of families with FA adapt to their child’s condition over time, and 
report normal levels of anxiety, some families experience an exacerbation of these symptoms upon 
and after diagnosis of their child’s FA (Zijlstra et al., 2010).  It has been suggested that the constant 
vigilance required to look after children with FA can significantly increase anxiety (Warren, Otto, 
Walkner & Gulta, 2016).  This seems to be supported by findings showing that anxiety is a commonly 
reported problem in parents of children with FA, especially mothers (Lau et al., 2014), and the 
severity of this anxiety has been shown to subsequently impact their child’s HRQoL (Chow, Pincus & 
Comer, 2015).  This can be a difficult dilemma for parents, as a certain level of hypervigilance is 
appropriate when parenting children with FAs, especially those with a history of anaphylaxis.  For 
example, Mandell and colleagues (2005) reported that most families with a child with FA follow a 
similar pattern of anxiety, where the high anxiety levels immediately following their child’s diagnosis 
acts to motivate families to seek out information, support and guidance from different agencies and 
clinical resources.  Further results indicate that this was then often followed by a rapid decrease in 
anxiety once the family had established their specific coping strategies.  The authors reported that 
factors such as a new serious allergic reaction acted to increase anxiety again and necessitated a repeat 
of the aforementioned cycle.  However, in contrast to some families with maladaptive levels of very 
high anxiety over time, the authors indicated that some families with very low levels of anxiety often 
failed to keep up adequate levels of vigilance that act to keep children safe.  Again, families face a 
very real dilemma as they are forced to find the optimal balance between vigilance and risk (Warren, 
Otto, Walkner & Gupta, 2016), which will obviously differ from family to family due to certain 




It has been hypothesised that families of children with nut allergies may experience high 
stress due to the serious, and often life-threatening, reactions children with these allergies experience 
(Clark & Ewan, 2003; Cummings et al., 2010).  In a study of children with suspected peanut and 
hazelnut allergies undergoing double-blind placebo-controlled food challenges, Zijlstra and colleagues 
(2010) found both mothers and fathers had very high levels of anxiety just prior to the challenge.  In 
fact, their anxiety levels were comparable to those for individuals with test anxiety, women 
undergoing in vitro fertilisation, and pregnant women who had previously lost a child to Sudden 
Infant Death Syndrome (SIDS).  In similar studies, parents have reported constant, overwhelming 
worry, and paralysing fear resulting in a sense of daily struggle (Cummings et al.,  2010).  For 
example, Springston and colleagues (2010) found that among a sample of over 1000 caregivers of 
children with FA, 26% reported having extreme anxiety related to their child’s FA and a similar 
proportion said they felt extremely troubled by sadness about the burden related to their child’s FA.  A 
similar line of research suggests that parents of children with FA may be passing on their own 
negative feelings and anxiety to their child, which may be evidenced by the findings that there was a 
significant mismatch between their child’s own food allergy-related anxiety and their actual clinical 
history of reactions (DunnGalvin, Gaffney & Hourihane, 2009).  
Other Factors to Consider  
Perhaps one of the more obvious factors that can increase the impact FA has on the well-being 
of a family, is the number and severity of the child’s FAs.  This can be seen as an especially alarming 
idea when one considers how a review of the literature indicates many children with FA have multiple 
allergies (King et al., 2009).  Specifically, Springston and colleagues (2010) found more than three 
quarters of their large sample of more than 1000 caregivers of children with FA had multiple allergies 
with nearly half of this sample having experienced anaphylaxis.  Additionally, while developing the 
FAQL-PB scale, a measure of parent-perceived burden for their child’s FA, Cohen and colleagues 




three or more allergies.  Researchers have indeed investigated whether the experience of dealing 
with multiple allergies has an impact on the aforementioned variables such as HRQoL and anxiety.  
For example, LeBovidge and colleagues (2009) found that having multiple allergies predicted parental 
anxiety, distress, and other psychosocial variables, more so than for families with a single allergy.  
Despite the aforementioned studies, more research is warranted to gain a better understanding of these 
phenomena.  Specifically, there is currently a gap in the literature regarding the prevalence, form and 
seriousness of FA in children residing in New Zealand, and a lack of research investigating the 
psychological effect these FAs have on their primary caregiver.  
Summary 
In summary, currently the only recommended way to manage FA is to strictly avoid the 
allergen, which is a formidable task and places the weight of avoiding potentially fatal reactions 
squarely on the shoulders of children, adolescents, and/or their caregivers.  It is clear that this required 
vigilance can leave parents feeling a great sense of burden.  The studies detailed above have revealed 
increased anxiety levels in these families with FA, particularly in mothers.  Furthermore, HRQoL is 
clearly affected in children with FA; however, the mechanisms by which this happens are less clear.  
More specifically, the factors that may moderate the relationship between FA and a child or 
adolescent’s HRQoL are unclear.  Factors related to FA have been shown to be associated with 
decreased HRQoL and parental burden, such as evidence of multiple FAs and needing to carry 
adrenaline auto-injectors at all times.  Given the findings within the literature to date, and the lack of 
research conducted among the population within New Zealand, it can be seen as an important next 
step to develop a better understanding of the mechanisms that impact children’s functioning both 
positively and negatively.  Therefore, this study aims to identify specific moderators of the 
relationships between FA illness severity and child HRQoL.  Ultimately, this knowledge may inform 
tailored programmes that are designed to improve the HRQoL of children and families with FA by 




contribution to the literature by generating empirical data on the prevalence of FA in NZ, which is 








Internationally, rates of chronic health conditions in paediatric populations have been 
increasing steadily over the last five decades (Van Cleave, Gortmaker & Perrin, 2010) with 
approximately 18% of New Zealand youth experiencing at least one chronic health condition which 
has been associated with increased rates of emotional distress (Denny et al., 2014).  Chronic health 
conditions in children are seldom completely cured and many are shown to be increasing in 
prevalence in recent times (Van Der Lee, Mokkink, Grootenhuis, Heymans & Offringa, 2007).  FA is 
one of the most common chronic diseases seen in children with rapidly increasing prevalence rates 
internationally (Sicherer & Sampson, 2018), yet FA is still poorly understood in terms of underlying 
causes, management and treatment (Burks et al., 2012; Sampson, 2004; Sicherer, 2002).  
What is Food Allergy? 
Symptoms of FA, an adverse reaction to food stemming from the immune system (Knibb and 
Stalker, 2013), can be seen in a number of organs: the skin (e.g., urticaria, flushing, dermatitis), the 
gastrointestinal tract (e.g., vomiting, abdominal cramping, swelling of the tongue), the respiratory tract 
(e.g., sneezing, nasal congestion, wheezing, repetitive cough), and the cardiovascular system, (e.g., 
dizziness, hypotension and shock).  Research has also shown that cramping pain in the back and 
having a sense of ‘impending doom’ may also be present (Sampson, 1999).  The most severe reaction 
to FA, however, is anaphylaxis: a multi system reaction that can come on extremely quickly and lead 
to loss of life.  Food is the leading cause of anaphylaxis in children and is avoidable only by strict 
vigilance of the allergen.  Following exposure to the allergen, the respiratory system may be 
compromised, with shock and cardiovascular collapse in severe cases or when treatment is delayed 
(Akeson, Worth & Sheikh, 2007).  Unfortunately, to date, there is not a universally accepted definition 




with severe FA (Akeson et al., 2007).  Most severe allergic reactions are attributable to IgE-mediated 
allergy, just one form of food hypersensitivity (Sampson et al., 2006), which requires immediate 
administration of epinephrine typically via an adrenaline auto-injector (AAI), such as an Epipen 
(Sampson, 2006).   
Although IgE-mediated allergic conditions are responsible for the most severe of reactions in 
children, non-IgE-mediated disorders (e.g., eosinophilic gastroenteritis, dietary protein–induced 
enterocolitis) have been shown to adversely affect children’s well-being with symptoms such as 
vomiting, dysphagia and pain (Klinnert et al., 2015).  For these types of disorders, biopsy samples 
may be used to confirm this diagnosis, but individual foods that may be causing the disorder are, as 
yet, unable to be identified (Sampson, 1999).  Another food associated disorder affecting children is 
Coeliac Disease (CD), an autoimmune-mediated condition related to sensitivity to a component of 
gluten, which is found in wheat, rye, and barley.  Symptoms include abdominal pain, chronic vomiting 
and diarrhoea and are triggered by exposure to gluten in the diet.  Following a diagnosis of CD, it is 
necessary to carefully eliminate all foods containing gluten, which can be an incredibly difficult 
challenge that requires significant changes to a child’s diet and if not done carefully can lead to 
chronic inflammation and tissue damage (Sampson, 2003). 
Diagnosis of Food Allergy 
Usually FA diagnosis is performed by an allergist who evaluates a patient’s medical history, 
which informs their judgement about whether the problems are likely caused by immunologic 
mechanisms, and therefore either IgE-mediated or non-IgE-mediated.  This typically results in further 
testing (e.g., skin prick tests, blood tests) and oral challenges to verify the allergy.  Ultimately, the 
allergy diagnostic gold standard is considered to be a double-blind placebo-controlled food challenge 
(DBPCFC).  These challenges consist of a food challenge tailored to an individual’s age, previous 
reactions and test history, and are performed in a hospital or clinic setting with specialist medical staff 




intervention quickly and efficiently  (Nowak-Węgrzyn et al., 2009).  Common testing, such as skin 
prick tests are notorious for having limited predictive accuracy compared to DBPCFCs, therefore a 
positive result on these tests does not actually confirm FA, but merely shows a possible positive 
association between reactivity and the allergen.  
Food Allergy Prevalence Rates 
Obtaining accurate international prevalence rates is difficult, given the incredible 
idiosyncrasies of FA.  Over half of all countries worldwide had no available prevalence rates in a 
global survey of FA (Prescott et al, 2013), with only 10% of a sample of 89 countries having ideal 
prevalence rates obtained by the gold standard of FA diagnosis (i.e., DBPCFC).  Countries who 
presented data on prevalence showed rates ranging between 1% (Thailand) and 10% (Australia).  For 
example, the United Kingdom has a prevalence rate of 4% (Prescott et al., 2013).  Current estimates of 
FA worldwide suggest a prevalence rate of approximately 6-7% of children (Boyle et al., 2017) with 
unknown prevalence in ethnic minorities and low SES populations (Goodwin, 2017). 
Although there are currently no prevalence rates available for New Zealand, Australia reports 
the highest prevalence rate (10%) of childhood FA in the world (Osborne et al, 2011; Prescott et al, 
2013).  Given the fact that New Zealand and Australia have previously reported similarities in allergy 
presentation, such as egg being most common FA in children, which differs to most other countries 
where milk is the most common (Prescott et al, 2013), it seems a fair assumption that prevalence rates 
will likely be very high in New Zealand also.  This being said,  it is important to gain accurate data on 
FA in New Zealand so healthcare and support services can be tailored for these families. 
Increasing Prevalence of Food Allergy 
Although gaining accurate prevalence rates from research is challenging, due to lack of 
objectively assessed reliable data, FA rates appear to be increasing (Sicherer & Sampson, 2018) 
particularly in Western countries such as the United Kingdom, Australia, and the United States 




unclear, although a number of hypotheses are currently being investigated, such as Vitamin D 
deficiency, hygiene, and dual allergen exposure theories (Du Toit et al., 2018).  In a study of 
approximately 5300 Unites States households, Sicherer and colleagues (2010) found tree nut and 
peanut allergies have been increasing consistently in children younger than 18 years between 2002 
and 2010, but not in adults with these allergies, where rates remained relatively constant over time.  
Similarly, a large study of school students in over 1500 Australian schools identified increasing rates 
of children at risk for anaphylaxis between the years 2009 and 2014 (Loke et al., 2016).  Using United 
States data from the National Health Survey, Jackson and colleagues (2013) reported that FA 
prevalence rates in children under the age of 18 years rose from 3.4% to 5.1% between the years of 
1997 to 2011.  A study of general practices in the United Kingdom revealed prevalence for people 
with peanut allergy doubling between the years of 2001 and 2005, although overall this prevalence is 
lower than that reported in previously mentioned studies at 0.51 per 1000 cases, perhaps due to 
underreporting by General Practitioners (Kotz, Simpson & Sheikh, 2011).   
It is thought that FA prevalence rates will continue to steadily rise in developing countries as 
they start to adopt a more Westernised lifestyle (Tang & Mullins, 2017).  The increasing prevalence is 
particularly noticeable in older children and adolescents, which is concerning given the rate of 
fatalities are highest in this age group (Bock, Muñoz-Furlong & Sampson, 2007).  It is thought that 
this prevalence will continue to rise globally over the short to medium term until a cure for FA or 
effective treatment is discovered (Tang & Mullins, 2017).  
Costs of Food Allergy 
Although data on the costs of FA for New Zealand families has not yet been documented, 
preventing and treating FA in children costs nearly 25 billion dollars a year in the Unites States alone 
(Bilaver et al., 2016; Gupta et al., 2013).  The majority of these costs are carried by the families and 
include lost labour due to needing to take time of work to care for these children, and out-of-pocket 




funding for the cost of adrenaline auto-injector (AAI) (commonly referred to as an Epipen in New 
Zealand), which may mean the cost for many New Zealand families with allergy is even higher than 
countries such as Australia where families can receive two funded Epipens on prescription if they 
meet specific criteria (Kemp, 2003).   
In addition to the economic costs of FA, there is a very real form of emotional cost to 
managing this illness.  Specifically, research has shown that the sense of burden related to looking 
after children with FA is also increasing.  Specifically, in a global survey of existing data on FA, 
Prescott and colleagues (2013) found that none of the 89 countries investigated reported a declining 
FA-related burden.  Due to rates of FA, New Zealand and Australia were both considered high-burden 
countries, but worryingly, had the lowest rates of specialist care with less than three pediatric 
allergists per million people.  These rates suggest that majority of New Zealand families with FA will 
be unable to access face-to-face specialist care for allergy management, as these few doctors will 
likely be based in main city centres.   
Treatment of Food Allergy 
In the absence of a cure for FA, which has yet to be identified,  research has been focused on 
preventative treatment.  Although there has been some success with this approach, such as oral 
immunotherapy (Bégin et al., 2014), these therapies are currently only available in research settings in 
Australia and New Zealand, and their safety and efficacy are still being established (Sampath, 
Sindher, Zhang & Nadeau, 2018).  Thus, at present there is no publicly available cure for FA, and the 
mainstay of management involves constant vigilance and strict avoidance of the allergen, such as by 
constantly monitoring food labels in case commercial food products, which may have been safe, have 
had allergens added to them.                                                
 In order to maintain the aforementioned vigilance required to keep children with FA safe, 
constant label checking and trust in manufacturers is necessary for families with FA.  Strict avoidance 




products.  This problem is compounded as there is a large variation in clear labelling of these 
products, which requires constant ingredient checking by children, adolescents, and caregivers.  
Consequently, the primary means for treating FA is a vigilant avoidance of allergens typically 
contained in foods (Bollinger et al., 2006).   
 Research shows that while there have been improvements in labelling issues, there is still 
evidence of serious problems.  For example, an Australian and New Zealand study found that 10% of 
a sample of food allergic individuals had experienced allergic reactions due to unexpected traces of 
allergens in food, and 5% reported reactions due to incorrectly labelled commercial food products.  
Further, 20% of the sample stated that they often or always felt unsure about the food being safe for 
them when reading labels (“Consumer study on Food Allergen Labelling”, 2009).  An earlier study 
found 30% of respondents reported that they have contacted the manufacturer to check ingredients in 
food items, indicating clarity of information is still a big issue for families with FA (“Quantitative 
consumer survey”, 2003).  However, research indicates those with FA in New Zealand and Australia 
report more care in always reading labels for foods than do respondents from the United States (Vierk, 
Koehler, Fein & Street, 2007).                                                  
To gain a better understanding of the time families with FA spend on illness related issues, it is 
important to examine how FA is managed and treated.  Once a child has been exposed to an allergen 
and has experienced an allergic reaction, this is usually treated with antihistamine for a mild reaction, 
or with adrenaline, such as via an Epipen, for severe reactions, which will be followed up with 
hospital care in case of need for subsequent treatment (Sampson, 1999).  
The most severe type of objective reaction to food is anaphylaxis, a severe, multi-systemic 
reaction which may result in death, with an estimate of 1.32% of people affected by this condition 
over their lifetime in England (Sheikh, Hippisley-Cox, Newton & Fenty, 2008) and 0.5-2.00% in the 
United States (Lieberman et al., 2006).  Children and adolescents appear to be at greater risk for 
anaphylaxis (Lieberman et al, 2006).  Biphasic allergic reactions, where allergic symptoms reoccur 




2000).  These are more likely to occur in severe allergic reactions, therefore children who have 
experienced life-saving treatment may be monitored in hospital for several hours post recovery 
(Lieberman, 2005).   
Parent’s concern that their child might die from an allergic reaction is a very real phenomenon.  
Frequency of fatal and near fatal reactions has increased over time (Sampson, 1992).  In a study by 
Sampson (1992) reporting on 13 children with fatal or near-fatal reactions to foods, accidental 
ingestions were common.  Half of the six fatalities had been prescribed epinephrine but not one child 
had the device on them at the time of the reaction, with the majority of reactions occurring at school.  
These alarming statistics highlight the problem of relying on constant vigilance and avoiding allergens 
as the mainstay of FA treatment.  It also indicates that schools may not be well-equipped to deal with 
very severe allergic reactions, and children may be unreliable at constantly carrying their Epipen.  
These problems are not unique to populations from the United States, as evidenced by an Australian 
survey that revealed how two thirds of school-aged children with a history of anaphylaxis did not have 
Epipens available at school in conjunction with an emergency action plan and a staff member able to 
administer adrenaline (Boros, Kay & Gold, 2000).   
Accidental exposure to FAs, resulting in anaphylaxis, is the leading cause of adverse events in 
FA globally, with an estimated 30,000 episodes of anaphylaxis to foods (e.g., nuts, treenuts, fish, 
shellfish), resulting in emergency room treatment every year in the United States alone (Sampson, 
2003b).  An Australian survey revealed one in 166 school-aged children have previously experienced 
anaphylaxis (Boros et al., 2000), however fatalities from anaphylaxis are rare with estimates of one 
fatality per 3 million people every year (Moneret-Vautrin, Morisset, Flabbee, Beaudouin, & Kanny, 
2005).  In New Zealand, two FA-related fatalities have been documented between the years 1985 and 
2005 (Low & Stables, 2006). 
Despite the constant label checking in vigilance most families undertake every day, mistakes 
inevitably will happen.  Foods may be incorrectly labelled, ingredients on trusted foods may change 




their allergy, or children may find and consume a food not safe for them.  For children with a history 
of severe reactions, or clinical testing which indicates they may be at risk for a severe reaction, 
carrying an AAI is absolutely essential to keep them safe (Muraro et al., 2014). 
Although the requirement for carrying an AAI is obvious, if there is history of a very severe 
reaction needing life-saving intervention, determining the need for others with FA is more complex.  
FA research reveals large differences in criteria for needing to carry an AAI, which may act to confuse 
these families, create unnecessary stress if they are actually unlikely to need to carry one, and 
conversely, put children at risk by not prescribing an AAI in spite of them having risk factors for very 
serious reactions.  In a study of adults with FA in the Netherlands, the authors revealed a tendency for 
AAI’s to be overprescribed in patients presenting with mild allergic symptoms but underprescribed in 
those with serious reactions.  Specifically, AAI’s were only prescribed to 39% of patients following a 
severe allergic reaction presenting to their General Practitioner, and 60% of those presenting at an 
emergency department.  It was also found that AAI’s are being prescribed without proper advice and 
training and there is evidence of confusion over when to use AAI’s and corticosteroids (Le, Hoffen, 
Pasmans, Bruijnzeel-Koomen & Knulst, 2008).  Furthermore, patients have been shown to misjudge 
the necessity to seek emergency care for allergic reactions with many seeking emergency department 
care for both minor and severe reactions (Le et al., 2008).  Similarly, in a study investigating the 
prevalence of tree nut and peanut allergies in the United States, researchers found only 46% of 
children and even fewer adults were prescribed AAI’s despite nearly three quarters of the sample 
having previously experienced multi systemic allergic reactions (Sicherer, Muñoz-Furlong & 
Sampson, 2003).  
In a related study by Pinczower and colleagues (2013), results indicated that carrying an AAI 
was associated with poorer HRQoL, and that this was independent of previous anaphylaxis and likely 
multifactorial in nature.  Conversely, nearly three quarters of the parents in a study by Allen, Bidarkar, 
vanNunen & Campbell (2015) reported that carrying an AAI actually reduced stress and anxiety.  The 




an AAI could account for why carrying an AAI actually helped, rather than hindered, their day to 
day lives. (Allen et al., 2015). 
Parental burden and Food Allergy 
One factor that may exacerbate problems in families with FA that are already exhibiting high 
levels of anxiety is a sense of parental burden relating to managing FA.  Recently, a focus of FA 
research has been investigating this disease burden in parents of children with FA.  The Food Allergy 
Quality of Life- Parental burden Scale (FAQL-PB) scale is currently the only FA-specific measure of 
disease burden for parents (Cohen et al., 2004).  Research has revealed parents of children with FA 
report a high sense of burden related to looking after their children.  Nearly half of parents in a recent 
study investigating FA-related burden reported moderate to severe limitations in caring for their 
family, such as planning social activities, eating out, and entrusting their children’s care to others.  
One of the factors shown to affect parental burden the most is parenting children with multiple 
allergies or those with severe reaction histories (Allen et al., 2015).  In fact, its relationship with 
burden is stronger than needing to carry an AAI constantly, which is another factor known to increase 
stress on families with a child with FA (Pinczower et al., 2013).  
Other studies have shown FA has a significant impact on the day-to-day lives of families, 
affecting family social activities, meal preparation, school attendance, and family stress levels.  In 
fact, research by Bollinger and colleagues (2016) showed approximately 10% of these families choose 
to home school their children due to their concerns about keeping their children safe.  Parents also 
admitted avoiding school camps, school outings, sending children to preschool or day-care, going to 
restaurants, letting their children go to friend’s houses for play dates, camps, and sleepovers.   
Valentine and Knibb (2011) found that the burden of responsibility for caring for children with FA 
affected parents much more than children.  This suggests parents may be taking on the bulk of day-to-
day management to the extent of shielding their children from many of the FA-associated challenges.  




PB, with nearly all participants at least moderately troubled by social interactions and limitations.  
These authors also found that parental burden was higher for parents of children with multiple 
allergies and burden rates were very high.  For example, approximately 65% of the sample felt 
moderately or extremely troubled by the extra time required to prepare safe meals. 
Because there have been mixed findings into the precursors of maternal anxiety in parents of 
children with FA, it has been suggested that it is the daily burden of looking after children with FA 
rather than previous experiences, such as the severity of previous reactions and hospital admissions 
for allergic reactions, that are the key drivers of anxiety in this population (Cummings et al, 2010).  
Burden may be even higher for families dealing with idiopathic anaphylaxis where the trigger is 
unknown and avoidance is impossible (Mandell, Curtis, Gold & Hardie, 2005).  It is thought by some 
that overly cautious avoidance tactics, such as steadfastly avoiding foods with a ‘may contain’ 
warning may increase a sense of burden (Shaker, Shwartz & Ferguson, 2017).  In families instructed 
or opting to avoid all ‘may contain’ foods, the burden of painstakingly checking ingredients and 
dealing with inadequate labeling of foods has been found to be associated with impaired QoL 
(Cummings, 2010). 
Anxiety and Food Allergy 
It is clear from the literature that FA in children is problematic in a number of ways, largely 
due to the constant vigilance required by both children and their families.  Intuitively, it would seem 
likely this constant vigilance may result in increased anxiety for children given the tight control 
required around activities that usually bring joy, such as birthday parties and other social gatherings.  
Research has identified that FA does appear to impact a child’s level of anxiety, although this finding 
is inconsistent, suggesting a need for a larger pool of global research into the effect of anxiety in FA 
child populations.  Lyons and Forde (2004) found that adolescents with FA exhibited higher anxiety 
levels than published norms of high school students in the United States.  Similarly, Avery and 




group of children with insulin-dependent diabetes mellitus, especially fears relating to accidental 
ingestion and general anxiety about eating and managing their FA.  However, other studies have 
shown that children with FA had comparable or even lower anxiety scores overall than those in 
healthy norm populations (Cummings et al., 2010; Le et al., 2013; King et al., 2009; Roy & Roberts, 
2011). 
 Although LeBovidge, Strauch, Kalish, & Schneider (2009) found that children reported similar 
levels of anxiety to previously reported healthy norm populations, parents reported higher levels of 
anxiety in their children, especially when they had high symptoms of anxiety themselves.  Given that 
parental overprotection has been linked to higher levels of child anxiety, and the necessity for parents 
to model non-anxious coping behaviours (Ginsburg & Schlossberg, 2002), providing parents with 
adequate psychoeducation relating to both management of FA, and ways to model healthy ways of 
coping, is important in protecting children with FA who may be at risk for high anxiety.   
Similarly, anxiety can extend beyond the child and impact parents, especially mothers (King et 
al., 2009; Lau et al., 2014).  It has been argued that both a lack of information about managing 
allergies and the uncertainty parents of children with FA face daily is a key driver of anxiety (Kemp, 
Allen & Campbell, 2009).  This makes sense because parents seldom know when they are going to be 
faced with a child’s allergic reaction, or how severe it is going to be.  This may result in parents 
feeling ‘on edge’ on a daily basis.  Many families experience periods of heightened anxiety, such as 
on immediate diagnosis of FA (Gustaffson et al., 2002), and periods of calm, when they experience a 
healthy adaptation to life with FA (Klinnert et al., 2014).  A qualitative study by Mandell, Curtis, Gold 
and Hardie (2002) of 17 children who had experienced anaphylaxis and their parents, found fear and 
anxiety often increases during transitions, such as the time a child with FA starts school.  It is thought 
that this may be due to an inability to relax when young children are away from their parents 
immediate supervision (Gillespie, Woodgate, Chalmers & Watson, 2007) and increased risk of 




 There is a growing literature supporting the argument that FA in children is related to 
increased anxiety in parents.  For example, King and colleagues (2009) investigated anxiety in a 
sample of 46 parents of children with peanut allergy and found mothers reported significantly higher 
anxiety levels than both fathers in the sample and reported norm scores.  The authors surmised that 
this might be due to mothers taking on the bulk of FA-related tasks such as purchasing foods (i.e., 
requiring careful label-checking) and preparing meals.  Another study conducted by Cummings and 
colleagues (2010) of children with allergy to nuts found mothers had higher trait anxiety, representing 
a general tendency to feel anxious (Spielberger, 1973), than norm scores.  Counterintuitively, they 
found severity of allergy was not significantly related to parent anxiety, nor was having a prescription 
for an AAI.  In fact, the researchers found having an AAI prescription appeared to reduce anxiety, 
suggesting carrying one of these devices may help alleviate some fear parents feel about a future 
reaction, and their ability to cope with this challenge (Cummings et al., 2010). 
 Although the research has shown that parents of children with FA generally score higher than 
healthy norms for anxiety (Cummings et al., 2010), it has been argued that there may be an optimal 
level of anxiety for parents of children with FA in order to keep children safe and that a certain 
amount of overprotection is appropriate in children, especially those with a history of anaphylaxis 
(Warren, Otto, Walkner & Gupta, 2016).  Therefore, finding an optimal balance between vigilance 
and risk is necessary.  However, as the researchers pointed out, this is likely to differ between families 
and children given variability in FA presentation in children (Warren et al., 2016), as well as 
differences in family risk perception and perhaps their access to specialty care and support groups.  
Events out of the ordinary have been described as the most anxiety-provoking, such as sleepovers, 
parties and holiday celebrations, and transition periods, such as entering adolescence (Gillespie, 
Woodgate, Chalmers & Watson, 2007).   
 It has been argued that appropriate levels of anxiety could be helpful in effective allergy 
management by parents, such as engaging in support-seeking behaviours (Mandell, Curtis, Gold & 




keeping children with FA safe from accidental ingestion by avoiding problem foods and carrying an 
AAI (Knibb et al., 2012).  However, one study has shown that higher levels of anxiety did not actually 
result in increased adherence to allergy plans (Cummings et al., 2010).  Conversely, Mandell and 
colleagues (2005) found low anxiety levels was related to decreased vigilance and being prepared for 
a future allergic reaction.  Clearly, more research is needed to provide clarity about the protective 
nature of appropriate levels of anxiety in parents of children with FA to shield them from undue risk. 
Health-Related Quality of Life 
As well as the physical ramifications already detailed above, FA can also impact the lives of 
children in social, academic, psychological and socio-emotional ways (Chow et al., 2015; Cummings 
et al., 2010; Knibb & Stalker, 2012).  These dimensions are captured by the construct of Health-
Related Quality of Life (HRQoL).  HRQoL can be described as an individual’s perception of the 
influence of health status on physical, psychological, and social functioning, which is 
multidimensional and subjective in nature (Matza, Swensen, Flood, Secnik, & Leidy, 2004).  HRQoL 
also has positive (e.g., contentment) and negative (e.g., pain) dimensions (WHOQoL group, 1995) and 
can be influenced by both internal (e.g., mental health) and external factors (e.g., physical 
environment; Warren et al, 2016).  Valid and reliable HRQoL measures have clinical relevance that 
can help both patients and practitioners make informed treatment choices (Higginson & Carr, 2001).  
Because children have unique contexts (e.g., family, school, peers) that can mediate the impact 
of chronic disease, child measures of HRQoL need to capture this fact.  This is paramount in allergy 
research with children as this condition has a significant effect on the way they are able to interact 
with their peers due to social limitations (e.g., attending play dates, attending birthday parties, etc.).  
Fortunately, psychometrically rigorous generic HRQoL measures exist that are designed to examine a 
broad range of outcomes and measure the impact chronic disease has on overall functioning.  It is no 




healthy counterparts (Primeau et al., 2000; Valentine & Knibb, 2011) and children without FA 
(King, Knibb & Hourihane, 2009).   
A range of generic HRQoL measures have been used in FA populations, such as the Pediatric 
Quality of Life Inventory (Varni, Seid & Rode, 1999) for children, and the World Health Organisation 
Quality of Life assessment (The WHOQOL group, 1998) for adults (Chow et al., 2015 Valentine & 
Knibb, 2011).  Unfortunately, there is a lack of FA-specific measures for children and adolescents 
resulting in researchers using parent proxy reports of child HRQoL for those with FA, such as the 
Food Allergy Quality of Life Questionnaire-Parent Form (DunnGalvin, de BlokFlokstra, Burks, 
Dubois & Hourihane, 2008).  
Intuitively, it would seem that children with FA and experience with life-threatening allergic 
reactions likely have impaired HRQoL.  Research supports this hypothesis.  For example, Avery and 
colleagues (2003) found that children with peanut allergy reported significantly lower HRQoL than a 
control group of children with insulin dependent diabetes mellitus.  With that being said, it is still 
unclear whether specific FAs, such as peanut, have a greater impact on children’s HRQoL.  
DunnGalvin and colleagues (2008) did find that children with a peanut allergy had HRQoL that was 
impacted more than those with a different single allergy or even multiple allergies, with the author’s 
suggestion that this finding is due to the challenge in avoiding this allergen and required vigilance.   
Another study investigating HRQoL in children with peanut allergy by King and colleagues 
(2009), found these children had significantly poorer HRQoL than did their siblings without FA, as 
well as published healthy norms, with domains of school and physical health particularly impaired.  
Similarly, a study of 253 children by Sicherer and colleagues (2001) with FA found HRQoL to be 
significantly worse than previously established healthy norms.  Conversely, a study by Valentine & 
Knibb (2011) that utilised a group of children with FA as well as control group of children without 
FA, found only some children with FA had poorer HRQoL than the control group, with the majority 




significantly poorer HRQoL than both the control group of parents whose children did not have FA, 
and the children themselves. 
In families with FA, some parents experience levels of stress and distress that may affect the 
overall family functioning and ability to adapt to life with FA.  Although some parents are able to 
achieve a sense of emotional distance and normality from the challenges associated with FA, research 
has shown repeatedly that parents of children with FA are challenged by negative emotions such as 
guilt and excessive worry (Valentine & Knibb, 2011; Vickers, Maynard and Ewan, 1997).  
Unfortunately, these emotions can have an impact on their child, which was illustrated in a study of 
533 mothers of children with FA.  Specifically, Chow and colleagues (2015) found that the severity of 
the child’s allergy, maternal overprotection, and psychological distress were all significantly 
associated with poorer quality of life and/or functioning in their allergic children.  Furthermore, 
children of mothers who were more stressed had a stronger relationship between AAI use and child 
anxiety than did children of less-stressed mothers.  This research has helped provide a better 
understanding of how improved screening measures are needed to identify those at risk for further 
difficulties, both in terms of the child’s difficulties and maternal distress, which may be impacting the 
child’s QoL (Chow et al., 2015). 
Theoretical Frameworks and Food Allergy 
In order to better understand the association between FA and associated psychological 
variables such as HRQoL and anxiety, it is necessary to investigate underlying theories that may help 
explain certain responses to allergic life and the maintenance of specific behaviours related to FA 
coping.  While no theoretical models specific to FA have been universally adopted, which makes it 
difficult for researchers to effectively develop prevention and treatment measures for the 
psychological effects of FA (DunnGalvin, Gaffney & Hourihane, 2009), Cognitive-Behavioural 
Theory (CBT) has been utilised to understand how maladaptive thought patterns can contribute to the 




the specific reaction they can expect when exposed to certain allergens, it is easy to imagine how a 
maladaptive pattern of thinking can develop.  For example, children may begin to perceive potential 
“threats” in multiple settings, imagine fatal outcomes with any exposure, etc.  As this pattern of 
thinking becomes more solidified, cognitively, this may subsequently impact the child’s behaviour 
and certainly their emotions (e.g., anxiety).  In fact, cognitive behavioural treatment has been 
recommended with a focus on isolating individual coping strengths and using emotional, behavioural 
and cognitive adaptive approaches to manage FA in order to relieve feelings of distress related to their 
condition (Polloni et al., 2015a).   
Further, the potential impact that parent behaviours can have on the development of this type 
of maladaptive thinking pattern is easy to see.  Thus, utilizing elements of Social Learning Theory 
(SLT) can also be seen as another means for understanding these psychological phenomena. In fact, 
asthma research has suggested an association between high maternal anxiety and child anxiety (Gupta, 
Mitchell, Gluffre & Crawford, 2001), and the aforementioned SLT framework may be one means for 
understanding this finding better.  Specifically, it has been suggested that maladaptive coping skills 
and overprotection exhibited by parents in response to stressful allergic experiences can result in 
children modeling anxious behavioural responses seen by their parents (Friedman & Morris, 2006). 
 In addition to the aforementioned CBT and SLT frameworks, other researchers have 
postulated other conceptualizations to help explain the relationships between FA and anxiety.  
Following a qualitative enquiry, DunnGalvin (2009) has proposed an integrated developmental 
framework in an attempt to understand maladaptive coping strategies utilised by children with FA in 
order to devise clinical interventions which can be targeted to this population.  This framework was 
organised into six main themes, and is explained from a developmental point of view.  These themes 
were peer relationships, risk and safety, coping strategies, meaning of food, control and self-efficacy 
and self/identity.  Although this research and proposed framework is promising in planning for 
effective healthcare, as yet, this framework has not been globally adopted or used in research to help 





The aforementioned research has clearly shown how FA can have a significant impact on a 
range of psychosocial variables such as HRQoL and anxiety.  However, a very limited body of 
research has focused on psychological interventions designed to improve functioning in either 
children or parents of children with FA.  In a study measuring the efficacy of FA-related interventions, 
Baptist and colleagues (2012) utilised a blind randomised controlled trial design to investigate a self-
regulation intervention for parents of children with FA.  This intervention involved three 25-minute 
telephone calls by a nurse trained in self-regulation pertaining to FA.  The calls discussed FA related 
concerns, goals and barriers, and then devised strategies to overcome the barriers.  Devising and 
developing coping mechanisms and strategies for living with FA were a key part of this intervention.  
At enrolment, 58 parent-child dyads were randomly assigned to either an intervention or control group 
and each family completed a measure of FA-specific parent perceived burden (i.e., FAQL-PB 
questionnaire; Cohen, Noone, Muñoz-Furlong & Sicherer, 2004).  Results indicated statistically 
significant improvements on the FAQL-PB scale post-intervention.  Specifically, domains of 
frustration, helplessness, anxiety and confidence were each significantly better post-treatment.     
Clinical interventions using a CBT framework have recently been trialed to examine changes 
in adaptive coping skills as a means for reducing anxiety in FA populations.  Specifically, a 
randomised clinical trial of 200 participants in the United Kingdom by Boyle and colleagues (2017) 
found that a single session of CBT improved anxiety and stress in mothers of children with FA a year 
following treatment.  The trial included psychoeducation with elements of risk information, relaxation 
training, and cognitive restructuring.  The authors suggested this work around risk perception may 
have been responsible, or partly responsible, for reduced maternal anxiety at the one year follow up 
given the likelihood of mothers’ constant worrying about negative outcomes.  The authors stated that 
health workers have a tendency to exaggerate the risk of fatal anaphylaxis when passing on risk 
information to families, which acts to increase anxiety.  Therefore, it was suggested there be a 




receive a prescription for an AAI (Boyle at al., 2017), but for families who have persistently 
problematic levels of anxiety, a short psychological intervention utilising CBT may be helpful in 
reducing anxiety.   
The nature of FA in families means that caregivers are trying to keep their children safe 
through constant vigilance (Klinnert & Robinson, 2008).  However, as highlighted above, many 
parents are also trying to manage their own stress, anxiety and decreased QoL associated with 
parenting a child with FA (Cummings et al., 2010).  Surprisingly, very few studies have investigated 
interventions designed to address the family system among families with a child diagnosed with FA. 
Thus, exploring the role of the parent, and the impact parent factors can have on child outcomes (e.g., 
HRQoL) can be seen as a critical next step in this line of research.  
Limitations 
There are a number of limitations to the reported studies.  Firstly, very few studies used both 
parent and child reports of child HRQoL despite the most commonly used measure, the PedsQL™, 
offering both child report and parent proxy forms for child HRQoL.  One study used parent report 
only of child HRQoL (Chow et al., 2015); while most used just child reported HRQoL (Shemesh et 
al., 2013; Valentine & Knibb, 2011).  This can be seen as problematic as parents who feel a great 
sense of burden in looking after their child with FA may overestimate the impact of FA on their 
child’s HRQoL.  Conversely, it is possible that parents do not actually realise the true impact of FA 
and will under report the impact on their child’s HRQoL.  Given caregivers inability to physically feel 
their child’s pain for ongoing allergic symptoms as well as the frustration of continually watching 
their child missing out in social situations involving food, it is possible children will actually rate their 
HRQoL as poorer than would their caregivers.  Parents may also put isolated allergic experiences into 
perspective better than children for developmental reasons.  Using both child self-report and parent 
proxy report, such as the present study aims to do, could result in a more accurate portrayal of the 




Another limitation, that is likely due to the fact that this body of research is in its infancy on 
some level, is that only a handful of studies have measured HRQoL among children with FA 
(Marklund et al., 2004; Valentine & Knibb, 2011; Warren et al., 2015).  Similarly, very little research 
exists that examines child anxiety (Cummings et al., 2010; Goodwin et al., 2017), parent anxiety 
(Cortes et al., 2018; Cummings et al., 2010), parental burden (Cohen et al., 2004; Leung, Yung, 
Wong, Li & Wong, 2009; Primeau et al., 2000; Warren et al., 2015) and moderating effects on child 
HRQoL (Chow et al., 2015) in children with FA and their parents.   
Further, there is a very limited body of quantitative research examining FA in children from 
New Zealand.  Research examining adults with FA has resulted in findings similar to those found 
internationally with children.  Specifically, research has shown that individuals with FA have 
significant difficulty eating safely, experience significant costs related to FA (i.e., emotional, 
financial), experience the burden of constant vigilance, experience fear and anxiety, perceive a lack of 
public awareness related to the seriousness of FA (e.g., restaurant staff), and experience feelings of 
isolation (Peniamina, Bremer, Conner & Mirosa, 2014).   
Rationale for the Present Study  
 Previous literature has demonstrated that the HRQoL is impaired in children with FA and that 
children with more severe allergies evidence poorer HRQoL.  The research also indicates that parents 
of children with FA feel a great sense of burden and often experience high levels of anxiety.  
However, no study to date has attempted to measure the relationships between these variables, and 
certainly not in a sample of children from New Zealand.  The present study will expand the literature 
by investigating the relationships between FA severity, anxiety, parent perception of burden, and child 
HRQoL in a New Zealand population.  Ultimately, this investigation aims to identify important 
variables that moderate the potential impact FA severity has on anxiety, parent perceived burden, and 
child HRQoL.  This research may inform evidence-based interventions that are designed to improve 






1. Children with FA will demonstrate lower levels of HRQoL compared to reported norms of children 
without FA. 
2. Children with more FA will demonstrate lower levels of HRQoL compared to children with one or 
two FAs. 
3. Severity of FA will be associated with lower levels of child HRQoL. 
4. Primary caregiver’s anxiety will moderate the relationship between FA and HRQoL, such that 
higher levels of anxiety, relative to lower levels, will be associated with lower HRQoL (see Figure 1). 
5. Primary caregiver’s sense of perceived burden will moderate the relationship between FA and 
HRQoL, such that higher levels of Parental burden, relative to lower levels, will be associated with 









Participants consisted of 154 dyads consisting of a parent/caregiver and their FA diagnosed 
child.  Specifically, primary caregivers were defined as the individual who was responsible for the 
day-to-day responsibility of allergy-related care, (e.g., preparing meals, shopping for food, checking 
food labels, etc.) for children with FA aged zero to 18 years.  Families were recruited from social 
media, quarterly magazines, email-based newsletters, and website advertising between August 2018 
and December 2018.  Recruitment was conducted via a collaboration between The University of 
Canterbury, Allergy New Zealand, and Coeliac New Zealand.  Allergy New Zealand is a New 
Zealand based charity that offers information, education, and support to families with children who 
have Food Allergy (www.allergy.org.nz).  Their ultimate goal as an organization is to help children 
with FA live an active and healthy lifestyle.  Coeliac New Zealand is a not-for-profit organisation that 
supports people with coeliac disease and those following a gluten free diet.  
Inclusion criteria for the study required that participants be the primary caregiver of a child 
aged zero to 18 years who suffered from IgE-mediated food allergy, non-IgE-mediated food allergy, 
or food related immune disorders (e.g., Coeliac Disease) along with that child.  Further, it was 
required that the child’s FA be medically diagnosed, rather than self-diagnosed or diagnosed by the 
parent.  In addition, children with issues that may have impacted their ability to complete the 
questionnaires and/or otherwise participate in the study (e.g., autism, developmental delays, etc.) were 
excluded and participants were required to understand and be able to write in English due to the fact 
that the previously validated measures being used were printed in English.  
Advertisements included a brief description of the study, the primary researcher’s contact 
information, and instructions related to requesting participation in the study (Appendix 1).  




have been made by a medical professional, and this was screened again within the family 
information form where participants were asked who made their child’s FA diagnosis, and what 
testing was used to verify this (e.g., skin prick testing RAST tests).  Following receipt of the 
advertisement, interested families contacted the primary researcher by e-mail, at which point the 
researcher mailed a research packet that included necessary instructions (Appendix 2), consent 
(Appendix 3), assent (Appendix 4), and research questionnaires to the family.  Advertisements by 
Allergy NZ and Coeliac New Zealand both targeted families with allergy throughout New Zealand 
and research packets were sent out Nationwide. 
Procedures  
The current study was approved by the University of Canterbury Human Ethics Committee 
(Reference: HEC 2018/63; Appendix 5).  Each family who expressed interest in participating via 
email correspondence received an envelope containing the research packet in the mail, which included 
research questionnaires and an information form describing the study and explaining the process of 
questionnaire completion.  The research packet also included a Parent Consent Form, Child Assent 
Form, and a pre-paid self-addressed return postage envelope for returning the questionnaires to the 
research team.  The packet also contained an allergy-themed wristband as a token of appreciation for 
the time each family dedicated to the study.  Once the packet was received by the family, the primary 
caregiver was instructed to carefully read the information sheet prior to completing the forms. If the 
primary caregiver agreed to participate, they were asked to complete the Parent Consent Form. The 
instruction form also asked the primary caregiver to read the Child Assent Form to the participating 
child, if necessary, or asked the child to read it for themselves if they were capable of doing so.  If the 
child also agreed to participate, they wrote their name at the bottom of the Child Assent Form.  For 
children too young to write, their parents signed on their behalf if the children agreed to consent.  
Families that had more than one child with FA were instructed to complete the forms for the child 




For children ages zero to 18 years, the primary caregiver was instructed to complete a 
modified version of the PedsQ™ Family Information Form (Appendix 6), the Food Allergy Quality of 
Life-Parental Burden Scale (Appendix 7), and the State-Trait Anxiety Inventory (Appendix 8).  For 
children ages five to 18 years, the target child was asked to complete the PedsQL™ Generic Core 
Scales (Appendix 9), and children ages eight to 18 years were instructed to complete the State-Trait 
Anxiety Inventory-Child form (Appendix 10).  These tasks were estimated to take approximately 20 
minutes in total.  Once the forms had been completed, the caregiver was instructed to return all 
research materials in the supplied pre-paid envelope addressed to the research team, which completed 
their participation in this research.  
Study Design  
The following investigation utilized a cross-sectional design to evaluate the relationships 
between several primary and secondary variables of interest.  Specifically, primary variables of 
interest included child illness severity, child HRQoL, child anxiety, parent anxiety, and parent 
perceived FA-related burden.  Ultimately, the moderating impact parent anxiety had on the 
relationships between child illness severity and HRQoL and the relationship between child illness 
severity and perceived burden were of primary interest.  
Data Collection and Entry 
Once the research packets were received by the research team, they were opened and checked 
for completeness and filed by grouped identification numbers in a locked filing cabinet in the primary 
supervisor’s office within the University of Canterbury Health Sciences building.  In an effort to 
maximize recruitment efforts, a reminder email was sent two months later to all email recipients who 
had expressed interest in receiving a research packet but had not yet returned it.  After this email a 
total of three families refused participation in the study for personal reasons relating to shared care. 
Consequently, of the 280 families who expressed interest in the study, 154 returned the questionnaires 




important to note, however, that data collection is ongoing and this response rate is increasing at 
present. Also important to note is that, due to the child anxiety measure being recommended for 
children eight years of age and older, no anxiety forms were completed for a portion of children in the 
sample.  Anxiety forms were completed for 70 children in the study. 
All data were entered into a software program for later analysis.  Specifically, IBM SPSS 
Statistics version 25 (SPSS Inc., Chicago, IL) was used for data entry, coding, and analyses.  First, a 
comprehensive data set was created that included each item from the research questionnaires.  
Responses for each questionnaire were entered into the database according to the individual 
questionnaire’s manufacturer instructions if available.  Specific categorical variables were created 
during the data entry process for individual allergies, comorbid conditions (e.g. eczema) and allergy 
symptoms (e.g. hives).  Additionally, string variables were created for several answers from the family 
information form, such as the name of the child’s medical condition, non-food-related allergies, who 
diagnosed the allergy and symptoms not related to allergy.  These were not coded for the current 
investigation, but were used for preliminary descriptive statistical analyses.  A variable for FA 
severity was calculated by summing frequency of anaphylaxis, the number of foods avoided, the 
number of symptoms experienced, history of ER visits and history of hospital admissions.  This is a 
slightly modified method used by Chow and colleagues (2015) in a similar study that also examined a 
moderational model among in families with FA. 
Measures 
Family Information Form 
 Demographic, allergy and additional family information was collected by parents using an 
adapted version of the PedsQL™ Family Information Form (Varni, Seid & Kurtin, 2001).  
Information collected included: (a) child age, gender, ethnicity, (b) parent occupation, marital status 




days children miss school due to their health, (d) details of the child’s allergy diagnosis, other 
medical conditions, number and reason for emergency department (ER) visits and hospital admissions, 
siblings with FA, history of anaphylaxis, allergy symptoms, comorbid conditions (allergy, eczema, 
dermatitis), non-food allergies, specific food allergies, and whether the child requires an Epipen.  
Again, please see Appendix 6 for the PedsQL™ Family Information Form. 
 Symptoms and signs entered in the database were a combination of subjective (e.g., nausea) 
and objective (e.g., uticaria, vomiting) symptoms reported by the primary caregiver and described in 
the family information form.  The food that was known to elicit the child’s FA, was recorded as 
‘unknown’ in the database if the patient reported an inability to discover the culprit allergen.  For 
example, if multiple foods had been eaten prior to the reaction and they were unsure what food had 
caused the reaction.  Symptoms were assumed to be absent if they were not reported, and all 
information contained in the family information form was entered into the database.  
Food Allergy Quality of Life-Parental Burden Form 
Perception of parent burden was assessed with the Food Allergy Quality of Life–Parental 
Burden questionnaire (FAQL-PB; Cohen et al., 2004).  This measure includes several areas of 
perceived burden that are relevant to caregivers of children who have FA, such as the time for 
preparing special meals (Bollinger et al, 2006).  The FAQL-PB has 17 items and uses a seven-point 
Likert scale ranging from a one for low trouble to a seven for a lot of trouble regarding the burden for 
each item.  Items include issues related to family life with FA, such as going away for holidays,  
dining out at restaurants, being able to work and put children in child care, time needed for meal 
preparation, health concerns, and emotional issues.  The FAQL-PB also measures worry about and 
ability to help children experiencing an allergic reaction, fear about allergic reactions in the future, 
sadness about FA-related burden the child carries, and frustration (Cohen, Noone, Muñoz-Furlong & 
Sicherer, 2004).  Scoring for the FAQL-PB involves entering the raw score for each item into the 




experienced by the primary caregiver.  Scores range from a 17 to 117, with mean total scores often 
calculated by dividing the total score by 17 (Knibb & Stalker, 2013).  Previous research indicates that 
the FAQL-PB possesses strong psychometric properties.  Specifically, studies have shown the FAQL-
PB has excellent test-retest reliability (0.93; Cohen et al, 2004) and internal consistency (α = 0.98; 
Leung, Yung, Wong, Li & Wong, 2009).   
PedsQL™ Generic Core Scales 
To evaluate child HRQoL, parents and their children completed the Pediatric Quality of Life 
Inventory Generic Core Scales (PedsQL™).  The PedsQL™ 4.0 Generic Core Scales are designed to 
assess generic HRQoL in children between the ages of two and 18 years, and include both parent-
proxy and child self-report forms (Varni, Seid & Rode, 1999).  Specifically, the PedsQL™ 4.0 
Generic Core Scales include a parent proxy-report form for children ages two to four years of age, and 
both parent proxy-report and child self-report forms for children ages five to 18 years.  Both the 
PedsQL™ parent-proxy and child self-report forms contain 23 items which include a Physical 
Functioning subscale (eight items) an Emotional Functioning subscale (five items), a Social 
Functioning subscale (five items), and a School Functioning subscale (five items).  In addition to these 
four scales and a total scale score, the scores also can be used to calculate a Psychosocial Health 
Summary score which is a combination of the Emotional, Social and School Functioning scales.  Both 
parent proxy-report and child-report scores were reverse scored and linearly transformed to a scale 
ranging from zero to 100 as recommended by the manufacturer (Varni, Seid & Kurtin, 2001).  Higher 
scores on this transformed scale represent better HRQoL.  The PedsQL™ 4.0 Generic Core Scales 
demonstrates excellent reliablity (α = 0.88; Varni, Seid & Kurtin, 2001; Varni, Seid & Rode, 1999) 
and has been validated in both clinical and non-clinical samples (Varni, Burwinkle, Seid & Skarr, 




State-Trait Anxiety Inventory (STAI) 
To evaluate anxiety in parents of this sample, caregivers completed the State-Trait Anxiety 
Inventory (STAI) for adults (Spielberger, Gorsuch & Lushene, 1970).  The STAI is a self-evaluation 
questionnaire with two sections of 20 items, measuring both trait and state anxiety.  Trait anxiety 
refers to an overall tendency to become anxious while state anxiety refers to the transitional feelings 
an individual is currently experiencing.  The STAI measure can be used to give an overall low, 
medium or high anxiety rating (Boyle et al., 2017; Spielberger, Gorsuch & Lushene, 1970), although a 
score of 40 is often used as a cut-off point for separating participants into low and high anxiety groups 
(Addolorato et al, 1999).  Versions exist in a variety of languages, including an English/New Zealand 
version where all items are rated on a four-point scale ranging from  ‘not at all’ to ‘very much so’ for 
the state form and ‘almost never’ to ‘almost always’ on the trait form.  Higher levels of anxiety are 
represented with higher scores, with a minimum score of 20 and a maximum 80 for both State and 
Trait anxiety sections (King, Knibb & Hourihane, 2009.  Previous research indicates that the STAI 
possesses strong psychometric properties.  Specifically studies have shown the STAI has excellent 
internal consistency (α = .91) and has been validated on both clinical and non-clinical samples 
(Crawford, Cayley, Lovibond, Wilson & Hartley, 2011; Speilberger & Edwards, 1973).      
State-Trait Anxiety Inventory for Children (STAI-C) 
The State-Trait Anxiety Inventory for children (STAIC) (Spielberger & Edwards, 1973) is a 
40-item self-evaluation questionnaire for children.  Similar to the STAI, it distinguishes between 
fleeting anxiety, named state anxiety, and a tendency for anxiety embedded in personality, named trait 
anxiety.  It is designed for children of eight years old and above to complete independently 
(Spielberger & Edwards, 1973).  The STAI–C differs slightly to the STAI in that all items are rated on 
a 3-point scale ranging from ‘hardly ever’ to ‘often’ with a high score representing higher anxiety 
levels.  For questions indicating presence of anxiety (e.g. upset, worried), the STAI-C State-Anxiety 




are scored a one, two or three.  For the STAI-C trait anxiety form, each item indicates the frequency 
of behaviour occurrence, and thus all items are scored a three, two or one for very often, sometimes, 
and hardly ever.  The scores for each scale range from 20 to 60.  The STAI-C has also been validated 
on both clinical and non-clinical samples and has demonstrated excellent reliability (α = .88; Kirisci, 








Preliminary Transformations & Analyses 
All preliminary transformations, preliminary analyses, and primary analyses were conducted 
using IBM SPSS Statistics version 25 (SPSS Inc., Chicago, IL).  Following data entry as detailed 
above, the manufacturer and/or measure developers’ instructions were followed relating to 
transformations, scoring and interpreting of summary scores.   
First, demographic variables (e.g., participant age, gender, and ethnicity) were examined for 
descriptive purposes.  Next, FA characteristics, such as associated symptoms, comorbid conditions 
(e.g., asthma, eczema), number of foods avoided were also examined for descriptive purposes and the 
means of major variables of interest (i.e., burden, anxiety, HRQoL) were calculated.		
Next, Pearson correlations and ANOVA were conducted to determine the degree to which 
child age, gender, family income and ethnicity were related to measures of anxiety (i.e., parent as 
measured on the STAI and child anxiety as measured on the STAI-C), measures of parental burden on 
the FAQL-PB, both parent and child-reports of HRQoL (i.e., PedsQL™ Generic Core Scales for 
toddlers and children), and other parent reported variables.  In instances where demographic variables 
were significantly related to primary variables of interest, those variables were controlled for in 
subsequent analyses where statistically appropriate.  
For the current investigation, child age was significantly related with parental burden (r = -.24, 
p = .01), and child reported HRQoL (r = .21, p = .05).  Child gender was significantly correlated with 
child anxiety (r = -.32, p = .01).  Family income was significantly related with parental burden (r = -
.16, p = .05), parent anxiety (r = -.23, p = .01), child anxiety (r = -.29, p = .04), and parent reported 
child HRQoL (r = .22, p = .05).  Consequently, those demographic variables were controlled for in all 






Demographic variables (e.g., child age, gender, ethnicity, family income) were examined for 
descriptive purposes and can be found in Table 1.  The average child who participated in the study 
was 7.11 years of age and 51.3% were male.  Parents in this sample described their child’s ethnicity 
predominantly as New Zealand European (72.1%), Māori (15.8%), Asian (8.6%), Pacific Island 
(2.5%), European (1.9%) and British (1.9%).  The median annual household income for the families 
participating in the study was between $100,000 and $150,000.   
In terms of other descriptive statistics, the average number of foods avoided due to allergy for 
children participating in the study was 5.08 (SD = 3.80), with number of foods avoided ranging from 
1.0 to 30.0.  The mean age at FA diagnosis was 1.49 years (SD = 1.97) and 3.1% of the sample had 
been hospitalized over the previous 12 months due to their FA, while 19.9% had visited the 
Emergency Department for FA-related issues.  Nearly one quarter of the respondents suffered from 
Coeliac Disease (24%), and almost all of the responding parents stated that their child’s FA had been 
clinically diagnosed by skin prick/blood test, or biopsy for those diagnosed with Coeliac Disease 
(98.7%).  For those with FA alone, the most common allergen was milk, and the most common FA-
related symptom was hives.  Details of common allergens and symptoms can be found in Table 2.  Of 
the sample, 44.2 % had experienced at least one anaphylactic reaction due to their FA, with the 
number of episodes ranging from one to 30 (M =1.49, SD =3.21).  A total of 24.7% of the children in 
the study with FA also had siblings with confirmed FA, and comorbid disorders were common among 
the sample (e.g., 67.5% suffering from eczema, 51.9% from asthma).  Lower rates of other allergy-
related conditions were found with just 1.9% reporting Eosinophilic Esophagitis (EOE) and 1.3% 
reporting Food Protein-Induced Enterocolitis Syndrome (FPIES).  Finally, 55.2% of families reported 





Health-Related Quality of Life among Children with Food Allergy  
To determine if significant differences existed between children with FA, when compared to 
their non-FA counterparts, the present sample means for total scale score and subscale scores on the 
PedsQL™ were compared with published means for healthy controls (Varni, Burwinkle, Seid, & 
Skarr, 2003).  Specifically, two T-Tests were conducted that examined differences of parent proxy-
reported and self-reported child HRQoL among children with FA and healthy controls.  As 
hypothesized, results indicated that child self-reported HRQoL total scale scores and subscale scores 
were significantly lower than healthy controls among the current sample (see Table 5).  In terms of 
parent reported child HRQoL, results indicated that total scale scores and emotional, social and 
psychosocial subscale scores were significantly lower than the healthy controls.  However, contrary to 
anticipated results, children with FAs physical and school subscales scores were not statistically 
significant different to healthy controls (see Table 5).   
Multiple Food Allergy and Health-Related Quality of Life 
To test the hypotheses related to the impact FA has on HRQoL, a series of regression analyses 
were conducted.  Specifically, to determine whether the total number of food allergies impacted child 
HRQoL, two linear regression analyses were conducted.  First, a regression analysis was conducted 
with the parent reported total number of foods avoided as the independent variable and the child 
reported PedsQL™ total scale score as the dependent variable.  Results indicated that the number of 
foods avoided by children with FA was not a significant predictor of self-reported child HRQoL, F 
(2,92) = 2.17, p > .05.  For the second regression analysis, parent reported total number of foods 
avoided was entered as the independent variable and the parent reported PedsQL™ total scale score as 
the dependent variable.  Again, results indicated that the number of foods avoided by children with FA 





Food Allergy Severity Impact on Child Health-Related Quality of Life 
To determine whether the severity of a child’s FA impacted his or her HRQoL in the present 
sample, two linear regression analyses were conducted.  The first regression analysis included 
entering the FA severity variable as the independent variable and child reported PedsQL™ total scale 
score as the dependent variable.  Results indicated that FA severity was not a significant predictor of 
self-reported child HRQoL, F(2,92) = 2.87, p > .05.  For the second regression analysis, the FA 
severity variable was entered as the independent variable and the parent-proxy PedsQL™ total scale 
score as the dependent variable.  Results from this analysis indicated that FA severity significantly 
predicted parent reported child HRQoL, F(2, 93) = 3.45, p < .05, such that the more severe the FA the 
worse the parent reported  child HRQoL. 
 
Moderation Analyses  
To test the hypothesis related to illness severity, child HRQoL, parental anxiety and parental 
burden, moderation analyses were conducted.  Specifically, hierarchical linear regression analyses 
were performed to examine whether parent anxiety and/or parental burden would moderate the 
relationship between FA severity and both parent and child reported HRQoL.  For the first analysis, 
FA severity, parent anxiety and parental burden scores were transformed to Z scores.  Next, two 
interaction terms were created by calculating a variable that was the product of the FA severity and 
parent anxiety Z scores, and the product of the FA severity and parental burden scores.  Finally, 
testing each model consisted of analyses that were conducted at three levels: 1) variables being 
controlled for (e.g., child age, family income) were entered into Step 1, 2) main effects (e.g., FA 
severity and parent anxiety or parental burden) were entered into Step 2, and main effects (i.e., 
interaction terms) were entered into Step 3.  Any significant interactions would be examined post-hoc 




Child-reported Health-Related Quality of Life 
Results from the first moderation analysis indicated that, contrary to the proposed hypotheses, 
no significant FA severity by parent anxiety interactions in the prediction of self-reported child 
HRQoL. That is, parent anxiety did not moderate the relationship between severity of FA and child 
HRQoL (B = 2.03, SE = 1.53, β = .14, p > .05).  Similarly, results from the second moderational 
analysis indicated no significant FA severity by parental burden interactions in the prediction of self-
reported child HRQoL.  Specifically, parent anxiety did not moderate the relationship between 
severity of FA and child reported HRQoL (B = 1.28, SE = 1.70, β = .07, p > .05). 
Parent-reported child Health-Related Quality of Life 
Results from the moderational analysis related to parent reported child HRQoL indicated no 
significant FA severity by parent anxiety interactions in the prediction of proxy-reported child 
HRQoL. That is, contrary to the hypotheses for the current study, parent anxiety did not moderate the 
relationship between severity of FA and child HRQoL (B = 2.19, SE = 1.75, β = .13, p > .05).  
Similarly, the final moderation analysis indicated no significant FA severity by parental burden 
interactions in the prediction of proxy-reported child HRQoL; parent anxiety did not moderate the 
relationship between severity of FA and child HRQoL (B = 0.62, SE = 1.86, β = .29, p > .05).  Due to 
the lack of statistically significant moderation findings, no post hoc probing needed to be performed.  
Tables 6-9 provide the step-by-step statistics for these regression analyses. 
 
Secondary Analyses  
Food Allergy Severity Impact on Anxiety  
In light of the finding that parent anxiety did not moderate the relationship between illness 
severity and child HRQoL, secondary analyses were performed to examine the direct relationship 




the child’s FA impacted anxiety in the present sample, two linear regression analyses were 
conducted.  The first regression analysis included entering the FA severity variable as the independent 
variable and child STAI-C trait anxiety subscale total score as the dependent variable.  Results 
indicated that FA severity was indeed a significant predictor of child anxiety, F(3,65) = 3.77, p =.01, 
such that the more severe the FA the greater the child anxiety was.  For the second regression analysis, 
again the total FA severity variable was entered as the independent variable, but parent trait anxiety 
subscale score was entered as the dependent variable.  Contrary to the first regression, results from 
this analysis indicated that the severity of the child’s FA did not predicted parent anxiety, F(2,138) = 
3.97, p > .05.  
 
Food Allergy Severity Impact on Parental Burden 
Given the lack of significance for the moderation analysis related to illness severity, parental 
burden, and child HRQoL, secondary analyses were conducted.  Specifically, to determine whether 
illness severity impacted parent-perceived burden in the present sample, a single linear regression 
analysis was conducted where illness severity was entered as the independent variable and parental 
burden was entered as the dependent variable.  Results indicated that FA severity was a significant 
predictor of parental burden, F(4,130) = 7.28, p < .01, such that the more severe the FA the greater the 
perceived parental burden.  
 
One Way ANOVA Group Comparisons 
Due to large variability in parent trait anxiety scores, a further analysis was performed to 
examine the relationship between parent anxiety and major study variables.  Specifically, to determine 
whether there were significant differences in child HRQoL and parental burden levels between 
families with certain anxiety cutoff scores, a one-way ANOVA was performed.  Caregivers were 
categorized into a new variable that had low anxiety, moderate anxiety, and high anxiety categories by 




scores.  The reason for dividing participants into three groups was to examine whether high anxiety 
levels, or both moderate and high anxiety levels, were predictive of impaired HRQoL as reported by 
both children and caregivers, and parental burden.  Participants who sat under the first cut point were 
placed into the low anxiety group, those who sat between the first and second cut points were placed 
into the moderate anxiety group, and those above the second cut point were placed into the high 
anxiety group.  Next, differences in HRQoL and parental burden were examined. Results indicated 
statistically significant differences between groups for parent reported child HRQoL (F(2,86) = 7.02, 
p < .01), child reported HRQoL (F(2,85) = 5.11, p < .01) and parental burden (F(2,141) = 9.66, p < 
.01).  Conversely, no statistically significant differences were found between groups for child anxiety 
(F(2,68) = 1.14, p =.326).  Please see Table 11 for results related to this analysis.  
These aforementioned results met the assumption of homogeneity of variances, but group sizes 
were unequal, therefore, a Games-Howell post hoc test was performed to identify where differences 
occurred between the anxiety groups.  Post hoc testing revealed statistically significant differences in 
parent reported child HRQoL for low (82.17 ± 17.56) and high (65.36 ± 13.42) anxiety groups, but not 
for medium and high anxiety groups (p= .18) or low and medium (72.58 ± 17.18) groups (p= .18).  
These results were repeated for child reported HRQoL with significant differences between low 
(81.43 ± 14.51) and high (68.70 ± 13.29) groups, but not for low and medium  (74.34 ± 15.34) groups 
(p=.14) and medium and high groups (p=.31).  Total parental burden was significantly greater for 
those in low (39.02 ± 22.63) and high (61.67 ± 23.96) anxiety groups (p=.000) and medium (49.81 ± 








The present investigation was designed to examine the relationship between disease severity, 
anxiety, parental burden, and HRQoL in families who have a child diagnosed with FA.  Specifically, it 
was hypothesized that children with FA would report significantly poorer HRQoL than their healthy 
counterparts.  It was also expected that children with multiple allergies would report lower levels of 
HRQoL compared to children in the sample with just one or two allergies.  Similarly, it was 
hypothesized that the child’s illness severity would impact their overall HRQoL.  Finally, it was 
hypothesized that both parent anxiety and parental burden would moderate the relationship between 
FA severity and child HRQoL, as reported by children and their caregivers. 
The present study revealed some unexpected findings.  For example, having multiple FAs did 
not predict child HRQoL, as reported by both children and their parents.  A child’s severity also did 
not predict child HRQoL as reported by children, and neither parent anxiety nor parental burden 
moderated the relationship between FA severity and child HRQoL.  However, a number of significant 
findings did result from this study.  Specifically, the finding that child HRQoL (i.e., parent proxy-
report, child self-report) for children with FA, was significantly poorer than established healthy norms 
supported the hypothesis for the current investigation.  In addition, as hypothesized, FA severity 
predicted lower child HRQoL scores as reported by parents, as well as child anxiety and parental 
burden.  
Child Health-Related Quality of Life 
This study confirms previous findings that FA has a significant impact on both child and 
parent-reported child HRQoL (Avery et al., 2003; Bollinger, 2006; Cummings et al., 2010).  This is a 
particularly important finding, as this is the first study with a New Zealand sample that demonstrates 




the present study found children reported HRQoL levels that were significantly lower than their 
healthy counterparts, which included both total scores and all subscale scores of the PedsQL™ 
Generic Core Scales.  This finding is similar to research that examined HRQoL among children with 
FA, among a non-New Zealand sample (Cummings et al., 2010; King et al., 2009).  Similarly, this 
finding was bolstered by the fact that parents also reported their child’s HRQoL as significantly 
poorer overall.  However, parents reported significantly lower levels of HRQoL for only emotional, 
social, and psychosocial domains, which is consistent with previous research (Cummings et al., 2010; 
Roy et al., 2011; Valentine & Knibb, 2011).   
As previously mentioned, the emotional domain of child HRQoL were reported as particularly 
impacted by both children and parents in the present sample, and significantly worse than scores 
reported for norm populations.  This finding is in keeping with another study of children with FA 
(King et al., 2009).  Given questions on the emotional domain of HRQoL involve fear, sadness, anger 
and worries, this finding is unsurprising.  Children with FA may struggle with fear about a repeat of 
an allergic reaction they have previously experienced, and may feel traumatised by needing an 
injection of epinephrine.  They may often worry about what might happen to them if they get exposed 
to an allergen unintentionally, or as part of clinical food challenges, which they may have failed in the 
past.  These children may also feel sadness or anger when they miss out on parties and social occasion 
due to their FA, or have to take special food and miss out on eating items such as birthday cake.   
As well as emotional domains of HRQoL, social domains were also particularly affected in the 
present sample as reported by both children and parents, and has also been reported previously 
(Cummings et al., 2010; King et al., 2009).  Items that make up this domain revolve around peer 
relationships, teasing, and being able to do things other children do.  It is possible that some parents 
have informed children who play with other children who have FA, especially nut allergies which tend 
to be associated with anaphylaxis, to take great care when playing with that child, which could be 




comorbid conditions such as asthma and eczema may be teased over these conditions, especially if 
the effects on their skin are highly visible.  A growing body of literature exists that focuses on FA-
related bullying, and this research reveals the impact bullying can have on the HRQoL of a child with 
FA (Lieberman et al., 2010; Shemesh et al., 2013; Torabi et al., 2016).   
The finding that children rated their HRQoL as universally lower than healthy controls is very 
important in gaining an understanding of how children with FA in New Zealand are being affected by 
this condition.  Specifically, tiredness is a feature of the physical domain in child HRQoL, which was 
reported by children as significantly worse than their peers.  It is possible that children in the present 
sample may feel more tired than their peers for a number of reasons: their bodies may be busy fighting 
constant allergic reactions, and given the high frequency of children who reported previous history of 
anaphylaxis, these reactions likely involve a number of body systems, and will consequently take 
some time to recover from fully.  Also, children in the present study were commonly allergic to many 
foods with 66% of the sample allergic to four or more foods.  Consequently, these children may be on 
heavily restricted diets which could possibly be a cause of fatigue.   
Multiple Allergies 
Perhaps the most interesting finding was that despite the vast majority of children in the 
present sample having multiple allergies, this was not significantly related to scores for child HRQoL 
as reported by both children and their caregivers.  Similarly, multiple allergies were not a significant 
predictor of parent anxiety.  This confirms previous, but counter-intuitive, findings that multiple 
allergies are not related to impaired HRQoL as reported by both children with FA and their parents, 
nor are they related to parent’s anxiety (Cummings et al., 2010;  King et al., 2009).  Given that 
parent’s anxiety was generally high, and children’s HRQoL was generally low, this finding suggests 
that factors other than avoidance of certain foods may be creating stress and anxiety in families with 
FA.  It is possible that multiple allergies in isolation is not a major stressor, but when this is added to 




HRQoL will be felt.  A potential limitation was that very few children in the present study actually 
had just one allergy (10.4%) to compare to, therefore much larger studies in a New Zealand 
population, or studies which capture children with less allergies, would help confirm this finding. 
Although multiple allergies were not associated with reports of child HRQoL, the number of 
allergies was, however, significantly related to both child anxiety and parent burden.  This is 
inconsistent with previous research showing no significant relationship between multiple allergies and 
child anxiety (King et al., 2009) but corresponds with research reporting increased burden in parents 
of children with multiple allergies (Allen et al., 2015; Fathi et al., 2016).  One explanation is that 
avoiding a lot of foods due to high numbers of allergens is particularly problematic in New Zealand 
populations.  Because it is a very small country, commercially produced products that are free from 
allergens are very new to the food market, and development is still in its infancy.  Consequently, there 
is little variety of these products and they are difficult to source and are very expensive.  Eating out is 
particularly difficult with very few outlets specialising in products suitable for children with FA.  For 
older children who want to go to malls and other places teenagers tend to gather, the unavailability of 
suitable food adds another layer of anxiety.  They are faced with going hungry until they can get safe 
food at home, or bringing food from home, which may be a source of embarrassment for older 
children.   
Lack of resourcing due to the small size of New Zealand is another potential source of anxiety 
for children with FA.  Only a few larger cities have dedicated allergy specialists, meaning children 
need to travel long distances to get to a source of high quality allergy advice.  This likely means 
majority of allergy care is passed over to General Practitioners (GPs), who may be overly conservative 
due to wanting to reduce as much risk as possible.  Allergy specialists may have different views to 
GPs resulting in conflicting advice being given to children with their caregivers.  Further, due to the 
lack of resourcing, families may turn to online support groups for further guidance, which while it 




advice.  This conflict may be a source of increased anxiety for children trying to learn how to 
manage their condition safely. 
Intuitively this finding makes sense in that items on the burden scale involve daily challenges 
associated with parenting a child with FA, such as cooking meals, leaving children with others and 
social restrictions, which would likely be impacted more if the number of foods needing to be avoided 
was higher.  For example, if a child had one allergy such as a fish or shellfish allergy, cooking meals 
and buying food is relatively simple.  However, well over half of the children in the study had four or 
more allergies so it is easy to imagine how difficult life becomes when parents need to check 
ingredients and cook meals without foods such as wheat, dairy and egg as well as fish.  It is also easy 
to see why children with multiple allergies might have higher levels of anxiety.  These children have 
likely experienced more allergic reactions than those with one or two allergies, and each time a young 
child experiences a reaction to a new food, they may end up with a negative association to that 
experience.  As these experiences increase over time as foods are being introduced, they may begin to 
fear the introduction of a new food generally.  These fears may generalise to other parts of their life, 
such as mealtimes, eating at school, and being around others who are eating, such as at social events. 
Food Allergy Severity 
The present examination of FA severity yielded mixed results.  In line with the study 
hypothesis, higher scores on FA severity predicted poorer ratings of child HRQoL as reported by 
parents.  This is in keeping with previous research identifying that FA severity predicts poorer parent 
reported child HRQoL (Chow et al., 2015) but contrasts with studies concluding FA severity does not 
predict poorer child HRQoL as reported by parents (Marklund et al., 2006).  Although FA severity 
predicted poorer ratings of child HRQoL as reported by parents, this significant finding was not 
replicated for child reported HRQoL.  This parallels findings by Cummings and colleagues (2010) 
who also found FA severity was unrelated to children’s own reports of their HRQoL.  Although these 




worse than children themselves, and this has been noted previously (King et al., 2009), another 
interpretation is that caregivers may actually have a more realistic understanding of the impact FA 
severity has on their child’s HRQoL.  For example, children may have limited knowledge and 
memory of severe reactions, as doctors and parents may have chosen to keep many details from them 
as a means of protection from trauma.  If considerable time has passed since a severe reaction, 
children may not remember many of the details whereas parents may recall these times, and their 
child’s fears at the time vividly, which may affect the way they rate their child’s HRQoL. 
Anxiety 
The finding that caregivers of FA children in the present sample self-reported higher anxiety 
than published norms from healthy populations is in line with previous studies (King et al., 2009; 
Klinnert et al, 2014).  The fact that levels of parent anxiety in the present study as measured by the 
STAI were in keeping with other studies of families with FA (King et al., 2009) or even higher than 
that reported in other FA studies (Lau et al., 2014; Zijlstra et al., 2010) suggests that parents of New 
Zealand children with FA are experiencing especially heightened anxiety related to their child’s 
condition.  This finding warrants further investigation, given the impact, high levels of anxiety are 
having on the caregiver, as well as the potential impact this may have on the child’s functioning.  For 
example, it has been suggested that anxiety may be a protective factor in families with FA (Warren et 
al., 2016).  It is possible that heightened anxiety may translate into appropriate vigilance, such as 
constant ingredient checking and taking care to avoid cross contamination.  However, it is important 
to consider parents of children with FA may be modeling maladaptive anxious responses for their 
child, especially during times of heightened stress such as mid-allergic reaction or during clinical 
testing for allergy.  The present study showed that parent anxiety was indeed predictive of child 
anxiety, suggesting that parents may in fact be “passing on” their anxiety via these mechanisms.  It is 
unclear whether child anxiety in the present sample stemmed from direct fear in their perception of 




heightened anxiety in immediate family members.  Regardless, further research in this particular 
area is clearly needed to better understand the relationship between parent and child anxiety among 
families with a child diagnosed as food allergic.  
Because parent anxiety has been found to be associated with child HRQoL as highlighted in 
the literature review, the present study set out to ascertain whether parent anxiety would moderate the 
relationship between FA severity and child HRQoL.  It was hypothesized that as FA severity 
increased, higher levels of anxiety would negatively impact child HRQoL.  Contrary to the study 
hypotheses, parental anxiety was not found to moderate this relationship for either child self-report 
nor parent proxy-reported child HRQoL.  These results suggest that the relationship between severity 
and both child and parent reports of child HRQoL were no stronger or weaker among children whose 
parents are challenged by feelings of anxiety.  While there are several potential explanation for the 
lack of findings in this area, one might be that parent anxiety is indeed a protective factor.  At the very 
least, it is important to consider how the measures used in this study, while certainly psychometrically 
robust and considered a widely accepted measure of anxiety, did not distinguish between “general 
anxiety” and “food allergy-related anxiety”.  To better understand potential moderating effects of 
parent anxiety on the relationship between FA severity and child HRQoL, this methodological issue 
may need to be addressed.  Specifically, it can be seen as an important next step to develop and 
validate measures that capture the idiosyncrasies of the anxiety experience of parents caring for 
children with FA.     
Parental Burden  
 Consistent with previous literature reporting that FA is associated with a great sense of 
parental burden (Allen et al., 2015; Cohen et al., 2004) the present study reports even higher parental 
burden than similar FA studies (Allen et al., 2015; Cohen et al., 2004; Leung et al., 2009; Warren et 
al., 2015).  Although this investigation did not evaluate the statistical significance of those differences, 




severity is a predictor of parental burden (Warren et al., 2015).  The study analyses also demonstrate 
how parents with high anxiety feel a deeper sense of burden than do those parents with lower levels of 
anxiety.  Taken together, these results imply that, for parents, the challenges of caring for a child with 
FA may lie in the day-to-day burden of FA care, such as preparing safe meals and checking ingredient 
lists.  At the same time, relaxing activities which may counter this sense of burden, such as going out 
for meals and taking a holiday, can be especially difficult for families with FA.  This may also suggest 
that parents with anxiety that persists over time, such as that measured in this study, may be 
overwhelmed by feelings of worry and fear about the present and the future, which make the everyday 
allergy tasks feel even more burdensome. 
 Based on the emerging literature showing the burden in families with FA outlined in the 
literature review, the present study set out to ascertain whether that sense of parental burden would 
moderate the relationship between FA severity and child HRQoL.  It was hypothesised that those 
parents who had children with higher levels of disease severity, would also show evidence of lower 
levels of HRQoL if they perceived higher levels of FA related burden.   Contrary to study hypotheses, 
parental burden was not found to moderate the relationship between the FA severity and child 
reported HRQoL, nor was it found to moderate the relationship between FA severity and parent 
reported child HRQoL.  These results suggest that the relationship between severity and both child 
and parent reports of child HRQoL were no stronger or weaker among children whose parents felt a 
great sense of burden related to caring for a child with FA.  The reasons for this finding are unclear.  
One explanation may be that although parents are perceiving a greater level of burden, they are not 
expressing this in a way that is perceivable to their children.  Thus, the child’s HRQoL may be 
relatively unaffected.  Similarly, it may be that parents who perceive a higher amount of FA-related 
burden are doing more, in terms of managing their child’s illness, which could have a positive impact 
on their HRQoL in specific areas.  For example, it may be that parents are “carrying” the stress and 




predictive of parent reported impaired child HRQoL, it is possible parents are unaware of the way 
they are taking on the burden, and may be acting in more subconscious ways. 
The Effect of Burden and Anxiety on Child Health-Related Quality of Life 
Results from regression analyses indicate that the poorer child HRQoL reported by parents 
was significantly related to the child’s reports of anxiety and how much burden the parents perceived 
related to their child’s FA.  These results also suggest that children’s own reports of HRQOL are also 
related to their perceived anxiety and the burden the parents perceive to have.  This significant link 
between child anxiety and HRQoL has previously been identified (Roy & Roberts, 2011).  Contrary to 
the aforementioned postulation that children are not perceiving their parent’s burden in certain ways, it 
is possible that children are detecting the burden their parents are feeling resulting from their own FA 
in specific ways.  For example, the constant vigilance required in checking all labels and ingredients, 
and having to take food with them everywhere, may result in a higher level on anxiety for children 
with FA.  This constant vigilance could be both increasing children’s own anxiety and contributing to 
poorer HRQoL overall.   
Strengths of the study 
One of the major strengths of this study is that it utilised both parent proxy-report and child 
self-report of child HRQoL.  As discussed in the literature review, this is rare in FA research to date, 
where most studies have chosen either child or parent reports (e.g., Chow et al., 2015; Shemesh et al., 
2013; Valentine & Knibb, 2011).  Consequently, the results from the current investigation may help 
provide a more complete and accurate picture of child HRQoL for children diagnosed with FA.  
Specifically, the methods used in the current study allow for a comparison of HRQoL scores between 
the child and their parent, which can be seen as strength.  Intuitively it would seem likely that parents 
might rate their children’s HRQoL as worse than children themselves due to the role caregivers of 




continually applying creams.  However, the results from this study showed this was not the case, 
given both children and parents gave very similar ratings of child HRQoL overall. 
Another major strength of the study was that it represents the first study of its kind in that it 
included participants from New Zealand.  Additionally, the relatively large sample size (N=154) is 
higher than many other FA studies from larger countries, such as the United Kingdom and the United 
States (Allen et al., 2015; Bollinger et al., 2006; Cortes et al., 2018; Cummings et al., 2010; Lau et al., 
2014; Pinczower et al., 2103).  Consequently, the results represent a large cross-section of the actual 
population of children with FA in the country of New Zealand.  
 
Limitations of the study and directions for future research 
A number of study limitations should be considered.  Although the majority of FA studies 
have recruited by social media and allergy clinics, as done in the present study (Springston et al., 
2010; Valentine & Knibb, 2011; Williams & Hankey, 2016), a proportion of FA studies have recruited 
participants exclusively from allergy clinics (Lau et al., 2014; LeBovidge, Strauch, Kalish & 
Schneider, 2009; Mizuno, Ohya, Nagao, DunnGalvin & Fujisawa, 2016).  Consequently, the current 
investigation relied on allergy confirmation by the child’s caregivers rather than it being verified by a 
medical professional.  As noted in the results, 98.7% of the sample reported that their child’s allergy 
had been diagnosed by skin prick or blood tests, which is the clinical testing standard used by allergy 
specialists (Sampson, 1999), or by biopsy for children with CD.   
Another limitation for the present study was that the anxiety scale used for children is 
recommended for children from eight years of age.  Consequently, a number of children in the present 
sample were unable to complete measures of anxiety due to their age.  Despite this fact, the relatively 
high mean age of participants in the current study  (M=7.11 years), still allowed for 70 completed 




measured child reported anxiety (Herbert & Dahlquist, 2008; LeBovidge et al., 2009; Roy & 
Roberts, 2011).   
 Another limitation of the present study, which can be seen as a limitation for this area of 
investigation, is the lack of consensus over how to measure FA severity.  The current investigation 
utilized a method used by other researchers that have summed a range of allergy variables, such as 
frequency of anaphylaxis, number of symptoms experienced, and number of foods the child is allergic 
to (Chow et al., 2015). Others have used a dichotomous variable which separates those who have 
experienced anaphylaxis and those who have not (Allen et al., 2015).  One study used type and 
number of symptoms to determine FA severity (Cortes et al., 2018), and others have graded 
anaphylaxis into five levels (Sampson, 2003; Wassenberg et al., 2012).  Others have had parents rate 
the severity into four groups (Valentine & Knibb, 2011).  Clearly, a universal standard for estimating 
the severity of a child’s FA is warranted.  
Additionally, similar to previous investigations, the children in the present sample appear to be 
at the severe end of FA, which may be considered another limitation.  As previously stated, nearly half 
of the sample had experienced anaphylaxis, which has been noted previously (Cohen et al., 2004; Lau 
et al., 2014; Springston et al., 2010), but does not align with general prevalence rates for anaphylaxis 
in the general allergy population (Lieberman et al., 2006).  Furthermore, the children in the sample 
had more allergies than reported in other FA studies (Bollinger et al., 2006; Chow et al., 2015).  
Future research with a larger sample size and representation from a full range of children with FA, 
including those with a history of less severe reactions, and single allergies, would help ascertain if the 
results are generalisable to the full population of children with FA. 
The cross-sectional design of the present study can also be seen as a potential limitation.  
Although the results identified a relationship between anxiety, parental burden and HRQoL in children 
with FA, we cannot determine whether FA specifically caused the high rates of anxiety, burden and 




would help make causal inferences about the effect anxiety and parental burden has on the 
relationship between FA and HRQoL. 
Implications for clinical practice and research 
 These results of the current study have both practical and empirical implications.  Although the 
results suggest some children and parents of children with FA may have healthy and adaptive levels of 
overall functioning, the high rates of anxiety, parental burden and impaired HRQoL generally suggest 
clinicians working with these families need to be ready to identify families experiencing challenging 
psychological ramifications of FA, and be prepared to refer these families to appropriate services.  
Service providers should consider the implementation of screening protocols to identify families that 
may be experiencing heightened anxiety.  In cases where a child or family member is identified, 
having resources that include referrals or specialists in CBT may provide help for these families 
(Boyle, 2017).  Future research would do well to explore the efficacy of treatment protocols 
specifically designed to address the difficulties experienced by the allergy population further.  
Tailored interventions that target those difficulties, for both children with FA and their immediate 
family who may also be experiencing problems arising from their FA, could help improve the well-
being of those families.   
Another implication arising from the results is that educators may be able to provide support to 
parents feeling anxiety relating to their child’s FA.  This is important because educators are likely to 
see, and engage with, parents more often than do clinical specialists.  An understanding of the 
potential challenges and anxieties in both children with FA and their parents may help foster support 
for these families.  The research also highlights the impact FA has on a child with FAs ability to 
engage in regular social activities, which is important for educators to understand.  A creative 
understanding about how best to include children with FA in social events, whilst removing the stigma 






In summary, this study highlights the significant relationships between parent characteristics, 
such as parental burden and anxiety, with child HRQoL in children with FA.  It is clear FA can affect 
both children and their caregivers in both physical and psychological ways.  There was no evidence 
from our results that multiple allergies increase impairments in HRQoL in children with FA but mixed 
evidence about the effect FA severity has on child and parent reported child HRQoL.  Caregivers of 
children with FA who are experiencing anxiety, fear and overwhelming worry should be encouraged 
to seek help from an appropriate practitioner, as should parents of children exhibiting fearful 
responses which seem worrying.  CBT, with psychoeducation tailored to FA, may help reduce the 
burden of FA for both children and parents of children with FA.  Allergy specialists should be aware 
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Descriptive Data of Demographic Variables 
  
Variable n % 
 
Gender 
     Male 











Relationship   
     Mother 151 98.1 
     Father 3 1.9 
 
Family Income   
     0-25,000 1 0.6 
     25,001-40,000 8 5.2 
     40,001-70,000 13 8.4 
     70,001-99,999 41 26.6 
     100,000-150,000 46 29.9 
     150,000 + 40 26.0 
 
Age   
     0-23 months 10 6.5 
     2-4 49 31.8 
     5-7 27 24.0 
     8-12 46 29.9 









Descriptive Data of Food Allergy Variables as Reported by Parents  
Variable n % 
 
Carry Epipen 
     Yes 











Food Allergies    
     Cows Milk 88 57.1 
     Egg 84 54.5 
     Peanut 81 52.6 
     Treenuts 69 44.8 
     Wheat 17 11.1 
     Soy 16 10.4 
     Sesame 13  8.4 
 
Symptoms   
     Hives 117 76.0 
     Itchiness 115 74.7 
     Rash 114 74.0 
     Stomach upset 103 66.9 
     Vomiting 96 62.3 
     Lip/tongue swelling 75 48.7 
     Wheeze 70 45.5 
     Breathing Difficulty 64 41.6 
     Throat restriction 50 32.5 
 
Coeliac Disease 37 24.0 
 
Allergic Disease   
     Eczema 104 67.5 
     Asthma 80 51.9 
 
  Worst Allergic Reaction    
     Mild-Moderate 







Number of foods avoided 
     1 
     2-3 

















Descriptive Statistics of Primary Variables of Interest  
Variable Mean (SD) 
 
PedsQL™ Generic Core Scales 
 
     Parent Proxy-Report 74.64(17.39) 
     Child Self-Report 75.38(15.02) 
State Trait Anxiety Inventory  
     Adult Trait 40.08(10.38) 
     Adult State 37.03(11.32) 
State Trait Anxiety Inventory  
     Child Trait 46.06(8.37) 









Bivariate Correlations for Primary Variables of Interest 
Variables 1 2 3 4 5 6 7 8 9 
1.FAQL-PB -  
 





-        
3.Parent State 
Anxiety 




.13 -.37** -.55** -      
5.Child 
HRQoL 
-.34** -.37** -.48** .75** -     
6.Child Trait 
Anxiety 
.34** .42** .40** -.61** -.78** -    
7.Child State 
Anxiety 
-.62** .24 .12 -.36** -.45** -.60** -   
8.Illness 
Severity 
.22** -00 -.40 -.21* -.13 .26* .15 -  
9.Comorbid 
Conditions 







.16 .03 -.07 -.07 -.06 .16 .13 .71*
* 
.08 
Note. Higher scores on the PedsQL™ indicate better quality of life, whereas higher scores on the 
FAQL-PB indicate poorer quality of life. Inverse correlations between the two measures, therefore, 
indicate consistent reporting of quality of life on both measures. 
*p < .05, **p < .01 







PedsQL™ versus Healthy Control Norms 
 FA Sample 
 
Healthy Controls  T Score 
Child Reported HRQoL    
     PedsQL: Total 75.38 (15.02) 82.87 (13.16) 4.83***  
					Peds	QL:	Physical	 82.50 (15.24) 86.86 (13.88) 2.77*  
					PedsQL:	Emotional	 65.03 (21.04) 78.21 (18.64) 6.07***  
					PedsQL:	Social	 76.00 (20.71) 84.04 (17.43) 3.76**  
					PedsQL:	School	 73.72 (18.55) 79.92 (16.93) 3.24*  
					PedsQL:	Psychosocial 71.58 (16.88) 80.73 (14.70) 5.25***  
Parent Reported HRQoL    
     PedsQL: Total 74.64 (17.39) 81.34 (15.92) 3.76** 
     Peds QL: Physical  81.84 (16.52) 83.26 (19.98) 0.84 
     PedsQL: Emotional  60.99 (24.01) 80.28 (16.99) 7.85***  
     PedsQL: Social  76.82 (22.11) 82.15 (20.08) 2.35*  
     PedsQL: School  74.58 (21.02) 76.91 (20.16) 1.08 
     PedsQL: Psychosocial 70.80 (19.88) 80.22 (15.84) 4.63***  
PedsQL: Pediatric Quality of Life Inventory  
M: Mean Score 
SD: Standard Deviation 
*: significant at p<.05 
**: significant at p<.01 







Hierarchical Regression Examining Moderating Role of Parent Anxiety on Food Allergy Severity 
Predicting Child-Reported Health-Related Quality of Life 
Variable Entered B SE(B) β  
 
t R2 
Step 1     .04 
     Child Age .84 .45 .20 1.88  
Step 2     .13 
     Child Age .71 .42 .17 1.68  
     Parent Anxiety -.52 .15 -.35 -3.54**  
     FA Severity -.18 .18 -.10 -.97  
Step 3     .02 
     Child Age .67 .42 .16 1.61       
     Parent Anxiety -.55 .15 -.37 -3.68**  
     FA Severity -.09 .19 -.05 -.46  
     Severity x Anxiety 2.03 1.53 .14 1.33  
Parent Anxiety as measured by the State Trait Anxiety Inventory-Trait Scale. 
 *p < .001, **p < .01. 
R² = .04 for Step 1; Adjusted R² = .03 for Step 1; R² = .17 for Step 2; Adjusted R² = .14 for Step 2; R² 







Hierarchical Regression Examining Moderating Role of Parent Anxiety on Food Allergy Severity 
Predicting Parent-Reported Child Health-Related Quality of Life 
Variable Entered B SE(B) β  
 
t R2 
Step 1     .39 
     Family Income 2.95 1.59 .20 1.86  
Step 2     .13 
     Family Income 2.20 1.51 .15 1.46  
     Parent Anxiety -.57 .18 -.33 -3.27**  
     FA Severity -.35 .21 -.17 -1.67  
Step 2     .01 
     Family Income 2.00 1.52 .13 1.31       
     Parent Anxiety -.61 .18 -.35 -3.40**  
     FA Severity -.27 .22 -.13 -1.22  
     Severity x Anxiety 1.89 1.82 .11 1.04  
Parent Anxiety as measured by the State Trait Anxiety Inventory-Trait Scale. 
 *p < .001, **p < .01. 
 
R² = .04 for Step 1; Adjusted R² = .03 for Step 1; R² = .17 for Step 2; Adjusted R² = .14 for Step 2; R² 







Hierarchical Regression Examining Moderating Role of Parental burden on Food Allergy Severity 
Predicting Child-Reported Health-Related Quality of Life 
Variable Entered B SE(B) β  
 
t R2 
Step 1     .04 
     Child Age .83 .41 .21 2.03*  
Step 2     .25 
     Child Age .33 .37 .08 .89  
     Parental burden -.31 .06 -.50 -5.40**  
     FA Severity -.05 .16 -.03 -.30  
Step 2     .00 
     Child Age .36 .37 .09 .97       
     Parental burden -.30 .06 -.49 -5.09**  
     FA Severity -.27 .22 -.13 -1.22  
     Severity x Burden 1.28 1.70 .07 .75  
Parental burden as measured by the Food Allergy Quality of Life-Parental Burden Scale (FAQL-PB). 
 *p < .001, **p < .01. 
R² = .04 for Step 1; Adjusted R² = .03 for Step 1; R² = .29 for Step 2; Adjusted R² = .26 for Step 2; R² 







Hierarchical Regression Examining Moderating Role of Parental Burden on Food Allergy Severity 
Predicting Parent-Reported Child Health-Related Quality of Life 
Variable Entered B SE(B) β  
 
t R2 
Step 1     .05 
     Family Income 3.26 1.53 .22 2.14*  
Step 2     .39 
     Family Income 2.74 1.24 .18 2.21*  
     Parental burden -.41 .06 -.57 -6.75**  
     FA Severity -.16 .17 -.10 -.94  
Step 2     .39 
     Family Income 2.74 1.24 .18 2.20*       
     Parental burden -.41 .06 -.57 -6.34**  
     FA Severity -.17 .18 -.08 -.94  
     Severity x Burden .19 1.90 .01 .10  
Parental burden as measured by the Food Allergy Quality of Life Parental Burden Scale (FAQL-PB). 
 *p < .001, **p < .01. 
 
R² = .05 for Step 1; Adjusted R² = .04 for Step 1; R² = .39 for Step 2; Adjusted R² = .37 for Step 2; R² 







Regression Analyses between Food Allergy Severity and Major Study Variables 
Variable B (95% CI) t p-value R Square Adj. R 
Square 
Self Reported HRQoL -.23 (-.59-.13) -1.27 .00 .06 .04 
Parent Reported 
HRQoL 
-.39 (-.81-.02) -1.89 .02 .08 .06 
Parental burden .77 (.28-1.26) 3.11 .00 .18 .16 
Parent Anxiety -.02 (-.25-.21) -.16 .87 .05 .04 








Results of one way ANOVA by anxiety grouping (low, medium, high) 
Dependent 
Variable 








      
 Between 
Groups 
3792.25 2 1896.13 7.02 .002** 
      Within 
Groups 
23240.12 86 270.23   




      
 Between 
Groups 
2161.67 2 1080.83 5.11 .008** 
 Within 
Groups 
17.993.66 85 211.69   
 Total 20155.33 87    
Child 
Anxiety 
      
 Between 
Groups 
158.87 2 79.43 1.14 .326 
 Within 
Groups 
4740.91 68 69.72   
 Total 4899.78 70    
Parental 
burden 
      
 Between 
Groups 
11041.16 2 5520.58 9.66 .000** 
 Within 
Groups 
80597.33 141 571.61   
 Total 91638.49 143    









Figure 1: Anxiety as a Moderator of the Relationship between Food Allergy Severity and Child 
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Figure 2: Parental Burden as a Moderator of the Relationship between Food Allergy Severity and 



















































University of Canterbury Food Allergy Study 
Does your child have a medically diagnosed food allergy?  
(Note: this includes IgE-mediated immune reactions & other adverse immune reactions to foods e.g. 
coeliac disease) 
Are you interested in contributing your experiences of living with Food Allergy to research 
looking at the impact of food allergy on New Zealand children and their families? 
If your answer is yes to both questions above, please read on: 
My name is Malena Penney and I am a Masters student at the University of Canterbury. My research 
is investigating the impact food allergy can have on families. Specifically, we are looking at parental 
anxiety associated with Food Allergy, parental burden associated with Food Allergy, and child quality 
of life. Ultimately, we are hoping that the results from this study will inform future efforts designed to 
provide needed support for families who have a child with Food Allergy.  
*Participants should have a child aged 0- 18 years of age who has been diagnosed with a food allergy 
by a doctor.  
Study participants will be asked to complete questionnaires that will allow researchers to gain a better 
understanding of the impact Food Allergy can have on a family, particularly primary caregivers and 
the child with Food Allergy. These questionnaires will be mailed to you with return postage for 





If you are interested in participating in this study, or would like to find out more about what 
will be involved, please email the primary researcher, Malena Penney at mjp169@uclive.ac.nz  
If you don’t have access to email, please feel free to call the primary supervisor, Michael Steele, PhD. 
on +64-3-36-92935 ext. 92935 and the information forms can be mailed to you.  
Responding to this request will not obligate you to participate in this research.  
This study has been approved by the Department of Child and Family Psychology, University of 
Canterbury.  
If you have questions or concerns about this project feel free to contact either the primary researcher 
or her supervisor. 
Primary researcher: Malena Penney 
Department of Child and Family Psychology, University of Canterbury 
Email: mjp169@uclive.ac.nz  
Primary supervisor: Dr. Michael Steele 
Department of Child and Family Psychology, University of Canterbury 















Department of Child and Family Psychology 
Telephone: 0211792708  
Email: mjp169@uclive.ac.nz 
1 August 2018 
 
The role of Parent Perception of Burden on Child Health Related Quality of 
Life: Examining Functioning among Children with Food Allergy  
 
Instruction Sheet for study participants 
My	name	is	Malena	Penney	and	I	am	a	Masters	student	at	the	University	of	Canterbury.	My	
research	is	investigating	the impact Food Allergy has on families who have a child with a Food 
Allergy.   
	
In the envelope, you should find: 
1.Pediatric Quality of Life family information form, to be completed by the primary caregiver. 
2. Pediatric Quality of Life Inventory Generic Core Scales-Child Self-Report Form, to be 
completed by your child if they over the age of five or by the primary caregiver if aged under five 
3. State-Trait Anxiety Inventory (child), to be completed by your child, if they are eight years of 
age or older.  If your child is younger than eight, please leave this form blank. 
4. State-Trait Anxiety (adult) to be completed by the primary caregiver 
5. FAQL-PB (Food Allergy Quality of Life-Parental Burden) form, to be completed by the primary 
caregiver 
6. Return envelope complete with postage   
 
These forms should take about 20-30 minutes to complete.  Participation is voluntary and you have 
the right to withdraw at any stage without penalty.  Please ensure you respect your child’s wishes 
regarding their involvement in this study by explaining to them that participation is voluntary and 
that nobody will be upset with them if they decide not to participate.  You may ask for your raw 




relating to you.   Please note, for your security any identifying information will be kept separate 
from the data collection and will be backed up on University of Canterbury servers and stored for a 
period of five years. 
 
Who to complete the study for? 
If by chance you have more than one child with Food Allergy, please complete the forms for the 
child who you consider to have the most severe symptoms. 
 






Email:	michael.steele@canterbury.ac.nz  Telephone:	02108043218 
It is possible that some questions asked in this study may cause you or your child some distress. If you 
do experience stress or emotional distress when completing these questionnaires, and feel the need for 
support, please contact one of the following support agencies as soon as possible: 
 
Youthline 0800 376 633 
The Depression Helpline 0800 111 757 
Healthline 0800 611 116 
Lifeline 0800 543 354 
 
If you are seriously concerned about your own, or your child’s immediate safety, 
Call 111 or take them to the Accident and Emergency Department at your nearest hospital. 
For further information on where to access Mental Health Services, please go to: 
www.health.govt.nz/your-health/services-and-support/health-care-services/mental-health-services 
 
For services specific to Allergy, please contact Allergy New Zealand (www.allergy.org.nz) to access a 
volunteer regional support coordinator who provide general information about allergy.  This agency 




This project has been reviewed and approved by the University of Canterbury Human Ethics 
Committee, and participants should address any complaints to The Chair, Human Ethics Committee, 













Department of Child and Family Psychology 
Telephone: 021 1792708 
Email: mjp169@uclive.ac.nz 
1 May 2018 
 
The role of Parent Perception of Burden on Child Health Related Quality 
of Life: Examining Functioning among Children with Food Allergy 
 
My name is Malena Penney and I am a Masters student at the University of Canterbury. My 
Masters research will be investigating the impact Food Allergy has on families who have a child 
with a Food Allergy.   
 
If you choose to take part in this study, you and your child’s involvement in this project will be 
completing measures of Quality of Life and anxiety as well as a Food Allergy-specific scale 
measuring parental burden.  These 5 short measures will be mailed to you in one packet containing 
return postage and are expected to take approximately 30 minutes to complete.  
 
 
Participation is voluntary and you have the right to withdraw at any stage without penalty. You may 
ask for your raw data to be returned to you or destroyed at any point. If you withdraw, I will remove 
information relating to you. However, once analysis of raw data starts on approximately the 1st of 
August, it will become increasingly difficult to remove the influence of your data on the results. 
 
The results of the project may be published, but you may be assured of the complete 
confidentiality of data gathered in this investigation: your identity will not be made public. To 
ensure anonymity and confidentiality, any data will be stored securely in a locker in the Child and 
Family Psychology building on a password-protected flash drive, and any online documents will 
be stored on an IronKey flash drive with data encryption.  A thesis is a public document and will 
be available through the UC Library. 
 
Please indicate to the researcher on the consent form if you would like to receive a copy of the 





The project is being carried out as a requirement for a Masters in Science (child and family 
psychology) by Malena Penney (mjp169@uclive.ac.nz) under the supervision of Dr. Michael Steele, 
PhD who can be contacted at michaelsteele@canterbury.ac.nz.  He will be pleased to discuss any 
concerns you may have about participation in the project.   
 
It is unlikely, but possible that some questions asked in this study may cause you or your child some 
distress. If you do experience stress or emotional distress when completing these questionnaires, and 
feel the need for support, please contact one of the following support agencies as soon as possible: 
 
Youthline 0800 376 633 
The Depression Helpline 0800 111 757 
Healthline 0800 611 116 
Lifeline 0800 543 354 
 
If you are seriously concerned about your own, or your child’s immediate safety, 
Call 111 or take them to the Accident and Emergency Department at your nearest hospital. 
For further information on where to access Mental Health Services, please go to: 
www.health.govt.nz/your-health/services-and-support/health-care-services/mental-health-services 
 
For services specific to Allergy, please contact Allergy New Zealand (www.allergy.org.nz) to access a 
volunteer regional support coordinator who provide general information about allergy.  This agency 
also organises support group meetings where you are able to meet others facing similar challenges. 
 
This project has been reviewed and approved by the University of Canterbury Human Ethics 
Committee, and participants should address any complaints to The Chair, Human Ethics Committee, 
University of Canterbury, Private Bag 4800, Christchurch (human-ethics@canterbury.ac.nz). 
 
If you agree to participate in the study, you are asked to complete the consent form and return by 





Department of Child and Family Psychology 
Telephone: 021 1792708 




□ I have been given a full explanation of this project and have had the opportunity to ask 
questions. 
□ I understand what is required of me if I agree to take part in the research. 
□ I understand that participation is voluntary and I may withdraw at any time without 
penalty. Withdrawal of participation will also include the withdrawal of any information 
I have provided should this remain practically achievable. 
□ I understand that any information or opinions I provide will be kept confidential to the 
researcher and her supervisor, Dr. Michael Steele and that any published or reported results will 
not identify the participants.  I understand that a thesis is a public document and will be 
available through the UC Library. 
□ I understand that all data collected for the study will be kept in locked and secure facilities 
and/or in password protected electronic form and will be destroyed after six years.  
□ I understand the risks associated with taking part and how they will be managed. 
□ I understand that I can contact the researcher, Malena Penney (malena@penney.co.nz) or 
supervisor Dr. Michael Steele (michael.steele@canterbury.ac.nz for further information. If I 
have any complaints, I can contact the Chair of the University of Canterbury Human Ethics 
Committee, Private Bag 4800, Christchurch (human-ethics@canterbury.ac.nz) 
□ I would like a summary of the results of the project.  
□ By signing below, I agree to participate in this research project. 
 
 
Name: Signed: Date:   
 





















































University of Canterbury Private Bag 4800, Christchurch 8140, New Zealand. www.canterbury.ac.nz 
 
 





HUMAN ETHICS COMMITTEE 
Secretary, Rebecca Robinson 
Telephone: +64 03 369 4588, Extn 94588 
Email: human-ethics@canterbury.ac.nz  
 
Ref:  HEC 2018/63  
 
 










Dear Malena  
 
The Human Ethics Committee advises that your research proposal “The Role of Parent Perception 
of Burden on Child Health Related Quality of Life: Examining Functioning Among Children with 
Food Allergy” has been considered and approved.   
 
Please note that this approval is subject to the incorporation of the amendments you have provided 
in your emails of 19th and 31st July 2018.  
 







Professor Jane Maidment 
Chair 











































































































































Appendix 8: State Trait Anxiety Inventory (Adult Form) 
 
State Trait Anxiety Inventory (STAI) Sample Items 
 
Due to copyright laws, only five sample items from the measure may be included in the present 
document.  The scale asks for items such as these to be scored on a four-point scale. 
1. I feel pleasant 
2. I feel satisfied with myself 
3. I wish I could be as happy as others seem to be 
4. I feel like a failure 









Appendix 9: PedsQL™ Generic Core Scales Sample Forms 
 
Sample copy: do not use without permission.  PedsQL™, Copyright © 1998 JW Varni, Ph.D. 
All rights reserved.  Contact information for permission to use:  Mapi Research Trust, Lyon, 



























































































































































































































Appendix 10: State Trait Anxiety Inventory for Children (STAI-C)  
 
 




To Whom It May Concern, 
The above-named person has made a license purchase from 
Mind Garden, Inc. and has permission to administer the following 
copyrighted instrument up to that quantity purchased: 
State-Trait Anxiety Inventory for Children Sample Items: 
I feel upset 
I feel relaxed 
I worry too much 
I notice my heart beats fast 
Copyright © 1970 by Charles D. Spielberger. All rights reserved 
in all media. Published by Mind Garden, Inc. 
www.mindgarden.com 
Sincerely, 
Robert Most Mind Garden, Inc. www.mindgarden.com 
STAICH instrument ©1970 Charles D. Spielberger. All rights reserved in all media. 
Published by Mind Garden, Inc., www.mindgarden.com 
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